Two	O
distinct	O
signalling	O
pathways	O
are	O
involved	O
in	O
the	O
control	O
of	O
the	O
biphasic	O
junB	B-DNA
transcription	O
induced	O
by	O
interleukin-6	B-protein
in	O
the	O
B	B-cell_line
cell	I-cell_line
hybridoma	I-cell_line
7TD1	I-cell_line
.	O

We	O
have	O
measured	O
the	O
level	O
of	O
junB	B-RNA
mRNA	I-RNA
in	O
the	O
B	B-cell_line
hybridoma	I-cell_line
cell	I-cell_line
line	I-cell_line
7TD1	I-cell_line
,	O
under	O
interleukin-6	B-protein
(	O
IL-6	B-protein
)	O
stimulation	O
.	O

IL-6	B-protein
increases	O
junB	B-RNA
mRNA	I-RNA
in	O
a	O
biphasic	O
fashion	O
.	O

The	O
first	O
early-induced	O
peak	O
was	O
transient	O
and	O
likely	O
corresponds	O
to	O
the	O
well	O
documented	O
typical	O
junB	B-RNA
mRNA	I-RNA
,	O
stimulated	O
in	O
response	O
to	O
numerous	O
growth	B-protein
factors	I-protein
,	O
including	O
IL-6	B-protein
.	O

At	O
variance	O
,	O
the	O
second	O
peak	O
which	O
has	O
never	O
been	O
reported	O
previously	O
,	O
lasted	O
several	O
hours	O
.	O

As	O
a	O
consequence	O
of	O
its	O
effect	O
on	O
junB	B-RNA
mRNA	I-RNA
,	O
IL-6	B-protein
stimulated	O
,	O
in	O
a	O
biphasic	O
fashion	O
,	O
the	O
nuclear	O
accumulation	O
of	O
the	O
JunB	B-protein
protein	I-protein
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
IL-6	B-protein
regulation	O
occurred	O
exclusively	O
at	O
the	O
transcriptional	O
level	O
and	O
that	O
the	O
bimodal	O
increase	O
of	O
junB	B-RNA
mRNA	I-RNA
and	O
JunB	B-protein
protein	I-protein
can	O
be	O
accounted	O
for	O
by	O
a	O
biphasic	O
stimulation	O
of	O
junB	B-DNA
transcription	O
.	O

Furthermore	O
,	O
our	O
data	O
point	O
to	O
two	O
major	O
differences	O
between	O
the	O
mechanism	O
of	O
control	O
of	O
the	O
early	O
and	O
the	O
late	O
IL-6	B-protein
-induced	O
junB	B-DNA
transcription	O
waves	O
.	O

First	O
,	O
cycloheximide	O
strongly	O
potentiated	O
the	O
transcription	O
of	O
the	O
second	O
wave	O
,	O
whereas	O
it	O
failed	O
to	O
affect	O
the	O
early-induced	O
burst	O
.	O

Second	O
,	O
tyrphostin	O
,	O
a	O
tyrosine	O
kinase	O
inhibitor	O
,	O
impaired	O
the	O
expression	O
of	O
the	O
first	O
but	O
not	O
the	O
second	O
junB	B-RNA
mRNA	I-RNA
peak	O
.	O

Conversely	O
,	O
genistein	O
,	O
another	O
tyrosine	O
kinase	O
inhibitor	O
,	O
totally	O
abolished	O
the	O
expression	O
of	O
the	O
second	O
peak	O
of	O
junB	B-RNA
mRNA	I-RNA
whereas	O
it	O
did	O
not	O
affect	O
the	O
expression	O
of	O
the	O
first	O
peak	O
.	O

Altogether	O
these	O
data	O
indicate	O
that	O
,	O
in	O
7TD1	B-cell_line
cells	I-cell_line
,	O
IL-6	B-protein
controls	O
junB	B-DNA
transcription	O
in	O
a	O
biphasic	O
fashion	O
by	O
means	O
of	O
two	O
separate	O
transduction	O
pathways	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

3	NULL
,	NULL
Issue	NULL
of	NULL
January	NULL
20	NULL
,	NULL
pp	NULL
.	NULL

1261-1268	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Two	NULL
Distinct	NULL
Signalling	NULL
Pathways	NULL
Are	NULL
Involved	NULL
in	NULL
the	NULL
Control	NULL
of	NULL
the	NULL
Biphasic	NULL
jun	NULL
B	NULL
Transcription	NULL
Induced	NULL
by	NULL
Interleukin-6	NULL
in	NULL
the	NULL
B	NULL
Cell	NULL
Hybridoma	NULL
7TD1*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
11	NULL
,	NULL
1994	NULL
)	NULL
Roger	NULL
Rezzonico	NULL
,	NULL
Gilles	NULL
Ponziot	NULL
,	NULL
Agnes	NULL
Loubat	NULL
,	NULL
Dominique	NULL
Lallemand	NULL
$	NULL
,	NULL
Amanda	NULL
Proudfoot1	NULL
,	NULL
and	NULL
Bernard	NULL
Rossi	NULL
From	NULL
INSERM	NULL
U364	NULL
,	NULL
Faculté	NULL
de	NULL
Médecine	NULL
,	NULL
Avenue	NULL
de	NULL
Vallombrose	NULL
,	NULL
06107	NULL
Nice	NULL
Cedex	NULL
02	NULL
,	NULL
France	NULL
We	NULL
have	NULL
measured	NULL
the	NULL
level	NULL
of	NULL
junB	NULL
mRNA	NULL
in	NULL
the	NULL
B	NULL
hybridoma	NULL
cell	NULL
line	NULL
7TD1	NULL
,	NULL
under	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
stimulation	NULL
.	NULL

IL-6	NULL
increases	NULL
junB	NULL
mRNA	NULL
in	NULL
a	NULL
biphasic	NULL
fashion	NULL
.	NULL

The	NULL
first	NULL
early-induced	NULL
peak	NULL
was	NULL
transient	NULL
and	NULL
likely	NULL
corresponds	NULL
to	NULL
the	NULL
well	NULL
documented	NULL
typical	NULL
junB	NULL
mRNA	NULL
,	NULL
stimulated	NULL
in	NULL
response	NULL
to	NULL
numerous	NULL
growth	NULL
factors	NULL
,	NULL
including	NULL
IL-6	NULL
.	NULL

At	NULL
variance	NULL
,	NULL
the	NULL
second	NULL
peak	NULL
which	NULL
has	NULL
never	NULL
been	NULL
reported	NULL
previously	NULL
,	NULL
lasted	NULL
several	NULL
hours	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
of	NULL
its	NULL
effect	NULL
on	NULL
junB	NULL
mRNA	NULL
,	NULL
IL-6	NULL
stimulated	NULL
,	NULL
in	NULL
a	NULL
biphasic	NULL
fashion	NULL
,	NULL
the	NULL
nuclear	NULL
accumulation	NULL
of	NULL
the	NULL
JunB	NULL
protein	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
IL-6	NULL
regulation	NULL
occurred	NULL
exclusively	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
and	NULL
that	NULL
the	NULL
bimodal	NULL
increase	NULL
of	NULL
junB	NULL
mRNA	NULL
and	NULL
JunB	NULL
protein	NULL
can	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
a	NULL
biphasic	NULL
stimulation	NULL
of	NULL
junB	NULL
transcription	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
data	NULL
point	NULL
to	NULL
two	NULL
major	NULL
differences	NULL
between	NULL
the	NULL
mechanism	NULL
of	NULL
control	NULL
of	NULL
the	NULL
early	NULL
and	NULL
the	NULL
late	NULL
IL-6-induced	NULL
junB	NULL
transcription	NULL
waves	NULL
.	NULL

First	NULL
,	NULL
cycloheximide	NULL
strongly	NULL
potentiated	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
second	NULL
wave	NULL
,	NULL
whereas	NULL
it	NULL
failed	NULL
to	NULL
affect	NULL
the	NULL
early-induced	NULL
burst	NULL
.	NULL

Second	NULL
,	NULL
tyrphostin	NULL
,	NULL
a	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
,	NULL
impaired	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
first	NULL
but	NULL
not	NULL
the	NULL
second	NULL
junB	NULL
mRNA	NULL
peak	NULL
.	NULL

Conversely	NULL
,	NULL
genistein	NULL
,	NULL
another	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
,	NULL
totally	NULL
abolished	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
second	NULL
peak	NULL
of	NULL
jun	NULL
B	NULL
mRNA	NULL
whereas	NULL
it	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
first	NULL
peak	NULL
.	NULL

Altogether	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
,	NULL
in	NULL
7TD1	NULL
cells	NULL
,	NULL
IL-6	NULL
controls	NULL
junB	NULL
transcription	NULL
in	NULL
a	NULL
biphasic	NULL
fashion	NULL
by	NULL
means	NULL
of	NULL
two	NULL
separate	NULL
transduction	NULL
pathways	NULL
.	NULL

Interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
is	NULL
a	NULL
cytokine	NULL
which	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
biological	NULL
activities	NULL
including	NULL
B	NULL
cell	NULL
differentiation	NULL
,	NULL
acute	NULL
phase	NULL
response	NULL
to	NULL
injury	NULL
and	NULL
inflammation	NULL
(	NULL
1-4	NULL
)	NULL
,	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
and	NULL
neuronal	NULL
cell	NULL
and	NULL
macrophage	NULL
differentiation	NULL
(	NULL
5-8	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
described	NULL
to	NULL
promote	NULL
the	NULL
growth	NULL
of	NULL
some	NULL
murine	NULL
hybridoma	NULL
and	NULL
plasmocytoma	NULL
(	NULL
9-11	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
human	NULL
myeloma	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
signal	NULL
transduction	NULL
path	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
(	NULL
INSERM	NULL
)	NULL
and	NULL
Grant	NULL
6717	NULL
from	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
contre	NULL
le	NULL
Cancer	NULL
(	NULL
ARC	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

+	NULL
To	NULL
whom	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
33-98-37-77-02	NULL
;	NULL
Fax	NULL
:	NULL
33-98-81-94-56	NULL
.	NULL

§	NULL
Present	NULL
address	NULL
:	NULL
Oncogenic	NULL
Viruses	NULL
Unit	NULL
,	NULL
Dept	NULL
.	NULL

of	NULL
Biotechnology	NULL
,	NULL
Pasteur	NULL
Institut	NULL
,	NULL
25	NULL
,	NULL
Rue	NULL
du	NULL
Dr.	NULL
Roux	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
.	NULL

1	NULL
Present	NULL
address	NULL
:	NULL
Glaxo	NULL
Institute	NULL
for	NULL
Molecular	NULL
Biology	NULL
S.A.	NULL
,	NULL
14	NULL
,	NULL
Chemin	NULL
des	NULL
Aulx	NULL
,	NULL
1228	NULL
Plan-les-Ouates/Geneva	NULL
,	NULL
Switzerland	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL-6	NULL
,	NULL
interleukin-6	NULL
;	NULL
genistein	NULL
,	NULL
4',5,7-trihydroxyisoflavone	NULL
;	NULL
tyrphostin	NULL
25	NULL
(	NULL
RG50875	NULL
)	NULL
,	NULL
(	NULL
3,4,5-trihydroxybenzi-lidene	NULL
)	NULL
-malononitrile	NULL
;	NULL
NF-IL-6	NULL
,	NULL
nuclear	NULL
factor	NULL
IL-6	NULL
;	NULL
MOPS	NULL
,	NULL
4-morpho-linepropanesulfonic	NULL
acid	NULL
.	NULL

ways	NULL
involved	NULL
in	NULL
the	NULL
mediation	NULL
of	NULL
these	NULL
various	NULL
effects	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

The	NULL
IL-6	NULL
receptor	NULL
is	NULL
composed	NULL
of	NULL
an	NULL
80-kDa	NULL
ligand-binding	NULL
subunit	NULL
associated	NULL
with	NULL
a	NULL
130-kDa	NULL
(	NULL
gp130	NULL
)	NULL
sig-nal-transducing	NULL
moiety	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

gp130	NULL
contains	NULL
a	NULL
large	NULL
intra-cytoplasmic	NULL
domain	NULL
lacking	NULL
homology	NULL
with	NULL
any	NULL
known	NULL
protein	NULL
kinases	NULL
or	NULL
other	NULL
proteins	NULL
carrying	NULL
a	NULL
catalytic	NULL
activity	NULL
.	NULL

Upon	NULL
binding	NULL
,	NULL
the	NULL
ligand	NULL
mediates	NULL
the	NULL
dimerization	NULL
of	NULL
gp130	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
one	NULL
tyrosine	NULL
kinase	NULL
belonging	NULL
to	NULL
the	NULL
Janus	NULL
kinase	NULL
family	NULL
(	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
or	NULL
Tyk2	NULL
)	NULL
(	NULL
15-17	NULL
)	NULL
.	NULL

In	NULL
response	NULL
to	NULL
IL-6	NULL
,	NULL
several	NULL
transcription	NULL
factors	NULL
are	NULL
activated	NULL
(	NULL
18-25	NULL
)	NULL
.	NULL

Along	NULL
this	NULL
line	NULL
,	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
acute	NULL
phase	NULL
protein	NULL
genes	NULL
have	NULL
been	NULL
investigated	NULL
ex-tensively	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
referred	NULL
to	NULL
as	NULL
nuclear	NULL
factor	NULL
NF-IL-6	NULL
(	NULL
C/EBP	NULL
$	NULL
)	NULL
was	NULL
initially	NULL
identified	NULL
as	NULL
a	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
AGATTGCACAATCT	NULL
consensus	NULL
sequence	NULL
encompassed	NULL
within	NULL
the	NULL
IL-6	NULL
promoter	NULL
(	NULL
26	NULL
)	NULL
.	NULL

This	NULL
factor	NULL
was	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
several	NULL
class	NULL
1	NULL
acute	NULL
phase	NULL
protein	NULL
genes	NULL
(	NULL
a	NULL
«	NULL
;	NULL
-acid	NULL
glycoprotein	NULL
,	NULL
angiotensinogen	NULL
...	NULL
)	NULL
by	NULL
IL-6	NULL
(	NULL
23	NULL
)	NULL
.	NULL

NF-IL-6	NULL
is	NULL
ubiquitous	NULL
,	NULL
inducible	NULL
at	NULL
the	NULL
transcription	NULL
level	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
protein	NULL
is	NULL
activated	NULL
by	NULL
phosphorylation	NULL
on	NULL
threonine	NULL
residues	NULL
by	NULL
microtubule	NULL
associated	NULL
protein	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Besides	NULL
NF-IL-6	NULL
,	NULL
IL-6	NULL
also	NULL
stimulates	NULL
the	NULL
activity	NULL
of	NULL
two	NULL
other	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
class	NULL
2	NULL
acute	NULL
phase	NULL
protein	NULL
genes	NULL
(	NULL
a	NULL
,	NULL
-macroglobulin	NULL
,	NULL
«	NULL
;	NULL
-antichymotrypsin	NULL
.	NULL

.	NULL

.	NULL
)	NULL

.	NULL

They	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
IL-6	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
and	NULL
acute	NULL
phase	NULL
response	NULL
factor/stat-3	NULL
(	NULL
20	NULL
,	NULL
25	NULL
,	NULL
28	NULL
)	NULL
.	NULL

IL-6	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
is	NULL
produced	NULL
in	NULL
an	NULL
activated	NULL
state	NULL
several	NULL
hours	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
IL-6	NULL
,	NULL
by	NULL
a	NULL
mechanism	NULL
involving	NULL
protein	NULL
neosynthesis	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
acute	NULL
phase	NULL
response	NULL
factor/stat-3	NULL
does	NULL
not	NULL
require	NULL
protein	NULL
synthesis	NULL
,	NULL
since	NULL
this	NULL
factor	NULL
is	NULL
directly	NULL
phosphorylated	NULL
by	NULL
the	NULL
Jak	NULL
family	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
and	NULL
translocated	NULL
in	NULL
the	NULL
nucleus	NULL
within	NULL
minutes	NULL
following	NULL
IL-6	NULL
stimulation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Several	NULL
reports	NULL
have	NULL
also	NULL
demonstrated	NULL
that	NULL
IL-6	NULL
triggers	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
160-kDa	NULL
protein	NULL
that	NULL
controls	NULL
in	NULL
turn	NULL
the	NULL
early	NULL
activation	NULL
of	NULL
jun	NULL
B	NULL
mRNA	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
,	NULL
one	NULL
possible	NULL
component	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
(	NULL
31	NULL
)	NULL
or	NULL
NFAT	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Under	NULL
IL-6	NULL
stimulation	NULL
,	NULL
the	NULL
transcription	NULL
of	NULL
early	NULL
jun	NULL
B	NULL
is	NULL
controlled	NULL
by	NULL
another	NULL
transcriptional	NULL
factor	NULL
,	NULL
that	NULL
interacts	NULL
with	NULL
an	NULL
IL-6-specific	NULL
cis-regulating	NULL
element	NULL
(	NULL
JRE-IL-6	NULL
)	NULL
located	NULL
at	NULL
position	NULL
-149	NULL
to	NULL
-124	NULL
of	NULL
junB	NULL
promoter	NULL
(	NULL
83	NULL
)	NULL
.	NULL

This	NULL
factor	NULL
is	NULL
activated	NULL
by	NULL
a	NULL
H7-sensitive	NULL
pathway	NULL
that	NULL
does	NULL
not	NULL
involved	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
protein	NULL
kinase	NULL
A	NULL
,	NULL
or	NULL
microtubule	NULL
associated	NULL
protein	NULL
kinases	NULL
(	NULL
33	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
IL-6	NULL
signaling	NULL
pathway	NULL
is	NULL
different	NULL
from	NULL
those	NULL
evoked	NULL
for	NULL
acute	NULL
phase	NULL
response	NULL
factor/	NULL
stat-3	NULL
or	NULL
NF-IL-6	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
the	NULL
study	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
junB	NULL
provides	NULL
an	NULL
interesting	NULL
approach	NULL
for	NULL
investigating	NULL
novel	NULL
IL-6-dependent	NULL
pathways	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
we	NULL
demonstrated	NULL
that	NULL
besides	NULL
its	NULL
ability	NULL
to	NULL
induce	NULL
early	NULL
junB	NULL
,	NULL
IL-6	NULL
can	NULL
also	NULL
stimulate	NULL
a	NULL
second	NULL
delayed	NULL
and	NULL
sustained	NULL
wave	NULL
of	NULL
expression	NULL
of	NULL
junB	NULL
mRNA	NULL
.	NULL

This	NULL
1261	NULL
1262	NULL
biphasic	NULL
increase	NULL
corresponds	NULL
to	NULL
two	NULL
transcriptional	NULL
bursts	NULL
,	NULL
resulting	NULL
subsequently	NULL
in	NULL
a	NULL
biphasic	NULL
increase	NULL
of	NULL
the	NULL
junB-en-coded	NULL
protein	NULL
(	NULL
JunB	NULL
)	NULL
.	NULL

We	NULL
also	NULL
provided	NULL
evidence	NULL
that	NULL
the	NULL
two	NULL
waves	NULL
of	NULL
junB	NULL
are	NULL
regulated	NULL
by	NULL
two	NULL
separated	NULL
pathways	NULL
that	NULL
are	NULL
controlled	NULL
by	NULL
distinct	NULL
tyrosine	NULL
kinases	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents-Recombinant	NULL
human	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
,	NULL
purified	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
34	NULL
)	NULL
,	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Glaxo	NULL
Institute	NULL
for	NULL
Molecular	NULL
Biology	NULL
(	NULL
Geneva	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

Culture	NULL
medium	NULL
was	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
(	NULL
Cergy	NULL
Pontoise	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Actinomycin	NULL
D	NULL
,	NULL
cycloheximide	NULL
,	NULL
genistein	NULL
,	NULL
tyrphostin	NULL
25	NULL
(	NULL
RG50875	NULL
)	NULL
,	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
and	NULL
human	NULL
thrombin	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
Western	NULL
blotting	NULL
kit	NULL
reagent	NULL
and	NULL
the	NULL
radioisotopes	NULL
[	NULL
a-*P	NULL
]	NULL
dCTP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
)	NULL
and	NULL
[	NULL
«	NULL
-*P	NULL
]	NULL
UTP	NULL
(	NULL
800	NULL
Ci/mmol	NULL
)	NULL
were	NULL
from	NULL
Amersham	NULL
(	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Rabbit	NULL
affinity-purified	NULL
polyclonal	NULL
anti-JunB	NULL
antibodies	NULL
(	NULL
JunB	NULL
2.2	NULL
)	NULL
used	NULL
in	NULL
Western	NULL
blotting	NULL
experiments	NULL
were	NULL
kind	NULL
gifts	NULL
from	NULL
Dr.	NULL
M.	NULL
Yaniv	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
URA	NULL
1644	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
antibodies	NULL
were	NULL
from	NULL
Dako	NULL
(	NULL
Denmark	NULL
)	NULL
.	NULL

QuickHyb	NULL
hybridization	NULL
solution	NULL
and	NULL
pBluescript	NULL
SK/	NULL
phagemid	NULL
were	NULL
purchased	NULL
from	NULL
Stratagene	NULL
.	NULL

PGEX-4T/2	NULL
vector	NULL
,	NULL
isopro-pyl-1-thio-B-p-galactopyranoside	NULL
,	NULL
and	NULL
glutathione-Sepharose	NULL
4B	NULL
were	NULL
from	NULL
Pharmacia/LKB	NULL
(	NULL
St-Quentin	NULL
Yvelines	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Cell	NULL
Culture-TTD1	NULL
cells	NULL
(	NULL
2.5	NULL
to	NULL
3.5	NULL
x	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
maintained	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
in	NULL
8	NULL
%	NULL
CO	NULL
,	NULL
atmosphere	NULL
,	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
culture	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
100	NULL
units/ml	NULL
IL-6	NULL
.	NULL

Within	NULL
kinetics	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
first	NULL
synchronized	NULL
in	NULL
G1	NULL
phase	NULL
by	NULL
depriving	NULL
them	NULL
of	NULL
IL-6	NULL
for	NULL
16-24	NULL
h	NULL
,	NULL
then	NULL
restimulated	NULL
by	NULL
the	NULL
cytokine	NULL
for	NULL
indicated	NULL
times	NULL
.	NULL

In	NULL
experiments	NULL
using	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
or	NULL
transcription	NULL
and	NULL
protein	NULL
synthesis	NULL
blockers	NULL
,	NULL
cell	NULL
viability	NULL
was	NULL
determined	NULL
in	NULL
parallel	NULL
by	NULL
trypan	NULL
blue	NULL
staining	NULL
.	NULL

RNA	NULL
Extraction	NULL
and	NULL
Northern	NULL
Blot	NULL
Analysis-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
denaturation	NULL
in	NULL
guanidinium	NULL
thiocyanate	NULL
followed	NULL
by	NULL
pelleting	NULL
through	NULL
a	NULL
cesium	NULL
chloride	NULL
cushion	NULL
(	NULL
35	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
15-20	NULL
ug	NULL
of	NULL
total	NULL
RNAs	NULL
were	NULL
loaded	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
in	NULL
MOPS	NULL
buffer	NULL
,	NULL
containing	NULL
0.7	NULL
%	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
onto	NULL
nylon	NULL
Hybond	NULL
N*	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Probe	NULL
hybridizations	NULL
(	NULL
10°	NULL
cpm/	NULL
ml	NULL
)	NULL
were	NULL
carried	NULL
out	NULL
overnight	NULL
at	NULL
65	NULL
°C	NULL
in	NULL
a	NULL
QuickHyb	NULL
solution	NULL
(	NULL
Strat-agene	NULL
)	NULL
,	NULL
filters	NULL
were	NULL
washed	NULL
in	NULL
0.1	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
SDS	NULL
at	NULL
65	NULL
°C	NULL
for	NULL
1	NULL
h	NULL
and	NULL
finally	NULL
exposed	NULL
to	NULL
Amersham	NULL
Hyperfilms-MP	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Northern	NULL
blot	NULL
experiments	NULL
were	NULL
quantified	NULL
by	NULL
densitometric	NULL
scanning	NULL
using	NULL
a	NULL
computerized	NULL
microscopic	NULL
image	NULL
processor	NULL
Biocom	NULL
500	NULL
(	NULL
Biocom	NULL
,	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
comprising	NULL
a	NULL
PC/AT-compatible	NULL
microcomputer	NULL
,	NULL
a	NULL
real	NULL
time	NULL
imaging	NULL
processor	NULL
,	NULL
a	NULL
control	NULL
monitor	NULL
,	NULL
a	NULL
color	NULL
high	NULL
definition	NULL
monitor	NULL
,	NULL
and	NULL
a	NULL
Panasonic	NULL
WV-CD50	NULL
camera	NULL
.	NULL

cDNA	NULL
Probes-The	NULL
cDNA	NULL
probe	NULL
for	NULL
junB	NULL
mRNAs	NULL
was	NULL
a	NULL
0.7-kilobase	NULL
EcoRUVAccl	NULL
fragment	NULL
excised	NULL
from	NULL
Rous	NULL
sarcoma	NULL
virus-junB	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
clone	NULL
465	NULL
,	NULL
published	NULL
by	NULL
Ryder	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
murine	NULL
e-mye	NULL
cDNA	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr.	NULL
Dani	NULL
(	NULL
Nice	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Nuclei	NULL
Isolation	NULL
and	NULL
Run-on	NULL
Transcription	NULL
Assay-Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
7TD1	NULL
cells	NULL
(	NULL
2-4	NULL
x	NULL
10	NULL
``	NULL
)	NULL
and	NULL
run-on	NULL
transcription	NULL
assay	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Doglio	NULL
et	NULL
al	NULL
.	NULL

(	NULL
37	NULL
)	NULL
.	NULL

Nylon	NULL
filters	NULL
(	NULL
Hybond	NULL
N*	NULL
,	NULL
Amersham	NULL
)	NULL
spotted	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pBluescript	NULL
SK	NULL
containing	NULL
jun	NULL
B	NULL
or	NULL
e-mye	NULL
cDNA	NULL
were	NULL
hybridized	NULL
for	NULL
48	NULL
h	NULL
at	NULL
65	NULL
°C	NULL
with	NULL
10	NULL
``	NULL
epm	NULL
of	NULL
biosynthetically	NULL
*°P-labeled	NULL
nuclear	NULL
RNAs	NULL
,	NULL
then	NULL
washed	NULL
four	NULL
times	NULL
at	NULL
65	NULL
°C	NULL
for	NULL
2	NULL
h	NULL
with	NULL
2	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
.	NULL

Filters	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Amersham	NULL
Hyperfilms	NULL
MP	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
and	NULL
Immunoblot	NULL
Analysis-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
using	NULL
a	NULL
method	NULL
derived	NULL
from	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
nuclei	NULL
(	NULL
4-5	NULL
10	NULL
``	NULL
)	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
above	NULL
and	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
nuclear	NULL
extraction	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.25	NULL
mm	NULL
EDTA	NULL
,	NULL
0.37	NULL
m	NULL
NaCl	NULL
,	NULL
0.5	NULL
mi	NULL
dithio-threitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
2	NULL
mM	NULL
benzamidine	NULL
,	NULL
5	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
5	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
5	NULL
ug/ml	NULL
pepstatin	NULL
)	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
gently	NULL
rocked	NULL
for	NULL
30	NULL
min	NULL
then	NULL
centrifuged	NULL
for	NULL
30	NULL
min	NULL
at	NULL
25,000	NULL
rpm	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
precipitated	NULL
overnight	NULL
by	NULL
addition	NULL
of	NULL
300	NULL
mg/ml	NULL
ammonium	NULL
sulfate	NULL
.	NULL

Proteins	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
for	NULL
20	NULL
min	NULL
at	NULL
25,000	NULL
rpm	NULL
,	NULL
resuspended	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
:	NULL
20	NULL
mm	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
60	NULL
mm	NULL
KCl	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.25	NULL
mM	NULL
EDTA	NULL
,	NULL
0.125	NULL
mm	NULL
EGTA	NULL
,	NULL
supplemented	NULL
with	NULL
protease	NULL
inhibitors	NULL
and	NULL
dialyzed	NULL
twice	NULL
for	NULL
3	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
against	NULL
the	NULL
same	NULL
buffer	NULL
.	NULL

Nuclear	NULL
protein	NULL
samples	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
to	NULL
an	NULL
Immobilon	NULL
membrane	NULL
(	NULL
Mil-lipore	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
first	NULL
with	NULL
a	NULL
specific	NULL
anti-JunB	NULL
(	NULL
JunB	NULL
2.2	NULL
)	NULL
polyclonal	NULL
antibody	NULL
(	NULL
1:750	NULL
dilution	NULL
)	NULL
and	NULL
then	NULL
with	NULL
a	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
antibody	NULL
(	NULL
1:2,000	NULL
dilution	NULL
)	NULL
.	NULL

The	NULL
transferred	NULL
proteins	NULL
were	NULL
finally	NULL
detected	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
Effect	NULL
of	NULL
IL-6	NULL
on	NULL
junB	NULL
Transcription	NULL
and	NULL
Synthesis	NULL
A	NULL
16	NULL
12	NULL
a	NULL
_	NULL
10	NULL
&	NULL
4	NULL
sf	NULL
s	NULL
gx	NULL
E26	NULL
m	NULL
<	NULL
§	NULL
a	NULL
2	NULL
o	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
B	NULL
Time	NULL
(	NULL
Hrs	NULL
)	NULL
too	NULL
Ctg	NULL
in	NULL
ap	NULL
wt	NULL
.	NULL

soe	NULL
>	NULL
Who	NULL
-~	NULL
>	NULL
on	NULL
fue	NULL
wan	NULL
@	NULL
bntodber	NULL
abet	NULL
18	NULL
$	NULL
»	NULL
IL-6	NULL
(	NULL
Hrs	NULL
)	NULL
0	NULL
1	NULL
1.5	NULL
2	NULL
3	NULL
4	NULL
5	NULL
60	NULL
6.50	NULL
7	NULL
75	NULL
8	NULL
95	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
induction	NULL
by	NULL
interleukin-6	NULL
of	NULL
junB	NULL
and	NULL
e-mye	NULL
mRNAs	NULL
.	NULL

Growing	NULL
7TD1	NULL
cells	NULL
were	NULL
synchronized	NULL
by	NULL
IL-6	NULL
deprivation	NULL
and	NULL
restimulated	NULL
with	NULL
the	NULL
cytokine	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
prepared	NULL
,	NULL
loaded	NULL
on	NULL
agarose	NULL
gels	NULL
,	NULL
blotted	NULL
onto	NULL
nylon	NULL
membrane	NULL
,	NULL
and	NULL
hybridized	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
with	NULL
cDNA	NULL
probes	NULL
encoding	NULL
for	NULL
,	NULL
respectively	NULL
,	NULL
junB	NULL
and	NULL
c-myc	NULL
.	NULL

Panel	NULL
A	NULL
shows	NULL
the	NULL
densitometric	NULL
scanning	NULL
of	NULL
Northern	NULL
blot	NULL
experiments	NULL
of	NULL
IL-6-induced	NULL
jun	NULL
B	NULL
mRNA	NULL
.	NULL

Panel	NULL
B	NULL
shows	NULL
the	NULL
level	NULL
of	NULL
junB	NULL
(	NULL
upper	NULL
part	NULL
)	NULL
and	NULL
c-myc	NULL
(	NULL
lower	NULL
part	NULL
)	NULL
mRNA	NULL
estimated	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
level	NULL
of	NULL
ribosomal	NULL
18	NULL
S	NULL
RNA	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
as	NULL
a	NULL
control	NULL
of	NULL
the	NULL
total	NULL
RNA	NULL
level	NULL
.	NULL

Autoradiograms	NULL
presented	NULL
were	NULL
obtained	NULL
after	NULL
1	NULL
day	NULL
of	NULL
exposure	NULL
.	NULL

system	NULL
(	NULL
Amersham	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
procedures	NULL
.	NULL

Expression	NULL
and	NULL
Purification	NULL
of	NULL
a	NULL
Bacterially	NULL
Synthesized	NULL
Glutathione	NULL
S-Transferase-JunB	NULL
Protein	NULL
and	NULL
Immunoblotting-This	NULL
protein	NULL
was	NULL
derived	NULL
from	NULL
a	NULL
pGEX-4T	NULL
vector	NULL
(	NULL
Pharmacia	NULL
)	NULL
into	NULL
which	NULL
the	NULL
1.4-kilobase	NULL
junB	NULL
cDNA	NULL
,	NULL
encoding	NULL
for	NULL
the	NULL
full-length	NULL
protein	NULL
,	NULL
was	NULL
cloned	NULL
into	NULL
Smal	NULL
Xhol	NULL
sites	NULL
.	NULL

Isopropyl-1-thio-B-D-galactopyranoside	NULL
(	NULL
1	NULL
mM	NULL
for	NULL
6	NULL
h	NULL
)	NULL
treatment	NULL
of	NULL
bacteria	NULL
harboring	NULL
this	NULL
plasmid	NULL
grown	NULL
at	NULL
28	NULL
°C	NULL
,	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
soluble	NULL
66-67-kDa	NULL
protein	NULL
comprising	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
26-28	NULL
kDa	NULL
)	NULL
fused	NULL
with	NULL
the	NULL
39-kDa	NULL
JunB	NULL
,	NULL
respectively	NULL
.	NULL

Following	NULL
lysis	NULL
by	NULL
sonication	NULL
,	NULL
solubilization	NULL
with	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
and	NULL
centrifugation	NULL
to	NULL
remove	NULL
debris	NULL
,	NULL
the	NULL
protein	NULL
was	NULL
absorbed	NULL
on	NULL
ice	NULL
to	NULL
glutathione-Sepharose	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
then	NULL
washed	NULL
extensively	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.5	NULL
m	NULL
NaCl	NULL
.	NULL

The	NULL
39-kDa	NULL
JunB	NULL
protein	NULL
was	NULL
finally	NULL
eluted	NULL
from	NULL
the	NULL
column	NULL
by	NULL
cleavage	NULL
with	NULL
1	NULL
ug/ml	NULL
human	NULL
thrombin	NULL
for	NULL
1	NULL
h	NULL
at	NULL
25	NULL
°C	NULL
.	NULL

The	NULL
protein	NULL
(	NULL
50	NULL
ng	NULL
)	NULL
was	NULL
subjected	NULL
to	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
an	NULL
Immobilon	NULL
mem-brane	NULL
.	NULL

Immunoblotting	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
with	NULL
an	NULL
anti-JunB	NULL
(	NULL
JunB	NULL
2.2	NULL
)	NULL
antibody	NULL
.	NULL

RESULTS	NULL
JunB	NULL
mRNA	NULL
Is	NULL
Stimulated	NULL
in	NULL
a	NULL
Biphasic	NULL
Fashion	NULL
in	NULL
Response	NULL
to	NULL
IL-6	NULL
on	NULL
7TD1	NULL
Cells-The	NULL
jun	NULL
family	NULL
members	NULL
junB	NULL
and	NULL
c-jun	NULL
are	NULL
usually	NULL
transiently	NULL
stimulated	NULL
in	NULL
the	NULL
early	NULL
response	NULL
to	NULL
numerous	NULL
stimuli	NULL
including	NULL
IL-6	NULL
(	NULL
29	NULL
,	NULL
30	NULL
,	NULL
39	NULL
)	NULL
.	NULL

In	NULL
recent	NULL
reports	NULL
,	NULL
authors	NULL
have	NULL
demonstrated	NULL
that	NULL
,	NULL
besides	NULL
their	NULL
early	NULL
effect	NULL
on	NULL
c-jun	NULL
mRNA	NULL
,	NULL
effectors	NULL
like	NULL
thrombin	NULL
or	NULL
fetal	NULL
calf	NULL
serum	NULL
are	NULL
also	NULL
able	NULL
to	NULL
elicit	NULL
a	NULL
second	NULL
phase	NULL
of	NULL
c-jun	NULL
mRNA	NULL
induction	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
verify	NULL
whether	NULL
IL-6	NULL
was	NULL
also	NULL
able	NULL
to	NULL
stimulate	NULL
a	NULL
late	NULL
induction	NULL
of	NULL
junB	NULL
mRNA	NULL
in	NULL
7TD1	NULL
cells	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
level	NULL
of	NULL
junB	NULL
mRNA	NULL
within	NULL
the	NULL
10	NULL
h	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
IL-6	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
carried	NULL
out	NULL
on	NULL
total	NULL
RNAs	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
panel	NULL
B	NULL
,	NULL
revealed	NULL
that	NULL
IL-6	NULL
Effect	NULL
of	NULL
IL-6	NULL
on	NULL
junB	NULL
Transcription	NULL
and	NULL
Synthesis	NULL
A	NULL
anti	NULL
JunB	NULL
NLS	NULL
.	NULL

I	NULL
1	NULL
1	NULL
U	NULL
JunB	NULL
>	NULL
eipcren	NULL
«	NULL
ull	NULL
-	NULL
(	NULL
lle	NULL
IL-6	NULL
0	NULL
_	NULL
0.5	NULL
1	NULL
2	NULL
4	NULL
6	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
4	NULL
6	NULL
a	NULL
B	NULL
10	NULL
Ro	NULL
s	NULL
4	NULL
l	NULL
ste	NULL
«	NULL
»	NULL
i=	NULL
;	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Kinetics	NULL
of	NULL
induction	NULL
by	NULL
interleukin-6	NULL
of	NULL
nuclear	NULL
JunB	NULL
protein	NULL
.	NULL

IL-6-deprived	NULL
7TD1	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-6	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Nuclear	NULL
proteins	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
SDS	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
transferred	NULL
onto	NULL
nitrocellulose	NULL
membrane	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Immunoblots	NULL
were	NULL
then	NULL
probed	NULL
either	NULL
with	NULL
a	NULL
specific	NULL
anti-JunB	NULL
antibody	NULL
or	NULL
a	NULL
non	NULL
relevant	NULL
serum	NULL
(	NULL
N.1.S	NULL
.	NULL
)	NULL

and	NULL
developed	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
revelation	NULL
.	NULL

Panel	NULL
A	NULL
shows	NULL
the	NULL
biphasic	NULL
induction	NULL
by	NULL
IL-6	NULL
of	NULL
the	NULL
nuclear	NULL
JunB	NULL
protein	NULL
.	NULL

Panel	NULL
B	NULL
shows	NULL
the	NULL
comparative	NULL
migration	NULL
pat	NULL
tern	NULL
of	NULL
:	NULL
the	NULL
nuclear	NULL
JunB	NULL
protein	NULL
of	NULL
7TD1	NULL
cells	NULL
,	NULL
nonstimulated	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
for	NULL
1	NULL
h	NULL
with	NULL
IL-6	NULL
versus	NULL
a	NULL
nonphosphorylated	NULL
bacterially	NULL
expressed	NULL
JunB	NULL
fusion	NULL
protein	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
shows	NULL
nu	NULL
clear	NULL
proteins	NULL
of	NULL
7TD1	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-6	NULL
,	NULL
probed	NULL
with	NULL
a	NULL
non-relevant	NULL
serum	NULL
.	NULL

<	NULL
4	NULL
JunB	NULL
©	NULL
<	NULL
4	NULL
JunB	NULL
strongly	NULL
augmented	NULL
the	NULL
cellular	NULL
level	NULL
of	NULL
jun	NULL
B	NULL
mRNA	NULL
following	NULL
a	NULL
bimodal	NULL
fashion	NULL
.	NULL

The	NULL
first	NULL
peak	NULL
of	NULL
induction	NULL
reached	NULL
a	NULL
maximal	NULL
value	NULL
after	NULL
1	NULL
h	NULL
and	NULL
then	NULL
rapidly	NULL
declined	NULL
after	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
.	NULL

The	NULL
second	NULL
phase	NULL
which	NULL
was	NULL
more	NULL
sustained	NULL
occurred	NULL
between	NULL
5	NULL
and	NULL
9	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

The	NULL
stimulation	NULL
factors	NULL
estimated	NULL
by	NULL
scanning	NULL
the	NULL
bands	NULL
corresponding	NULL
to	NULL
junB	NULL
mRNA	NULL
were	NULL
,	NULL
respectively	NULL
,	NULL
around	NULL
13-fold	NULL
for	NULL
the	NULL
first	NULL
peak	NULL
and	NULL
4-	NULL
to	NULL
5-fold	NULL
for	NULL
the	NULL
second	NULL
peak	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

This	NULL
biphasic	NULL
increase	NULL
was	NULL
selective	NULL
since	NULL
IL-6	NULL
did	NULL
not	NULL
stimulate	NULL
or	NULL
modify	NULL
the	NULL
constitutive	NULL
level	NULL
of	NULL
c-myc	NULL
in	NULL
the	NULL
same	NULL
interval	NULL
of	NULL
time	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
panel	NULL
B	NULL
)	NULL
The	NULL
Biphasic	NULL
Stimulation	NULL
of	NULL
junB	NULL
mRNA	NULL
Is	NULL
Associated	NULL
with	NULL
a	NULL
Biphasic	NULL
Increase	NULL
in	NULL
JunB	NULL
Protein-To	NULL
determine	NULL
whether	NULL
the	NULL
biphasic	NULL
regulation	NULL
of	NULL
junB	NULL
mRNA	NULL
resulted	NULL
in	NULL
a	NULL
biphasic	NULL
accumulation	NULL
of	NULL
JunB	NULL
protein	NULL
,	NULL
we	NULL
have	NULL
assessed	NULL
,	NULL
by	NULL
Western	NULL
blotting	NULL
analysis	NULL
,	NULL
the	NULL
JunB	NULL
protein	NULL
level	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
7TD1	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-6	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
for	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
h.	NULL
Results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
panel	NULL
A	NULL
.	NULL

In	NULL
IL-6-deprived	NULL
cells	NULL
,	NULL
no	NULL
immunoreactive	NULL
JunB	NULL
protein	NULL
could	NULL
be	NULL
de-tected	NULL
.	NULL

The	NULL
level	NULL
of	NULL
protein	NULL
increased	NULL
markedly	NULL
when	NULL
IL-6	NULL
was	NULL
added	NULL
,	NULL
raised	NULL
a	NULL
maximal	NULL
level	NULL
after	NULL
1	NULL
h	NULL
,	NULL
before	NULL
declining	NULL
to	NULL
a	NULL
basal	NULL
level	NULL
at	NULL
4	NULL
h.	NULL
Then	NULL
the	NULL
protein	NULL
level	NULL
increased	NULL
again	NULL
by	NULL
6	NULL
h	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
biphasic	NULL
stimulation	NULL
of	NULL
jun	NULL
B	NULL
mRNA	NULL
was	NULL
accompanied	NULL
by	NULL
the	NULL
increase	NULL
of	NULL
the	NULL
nuclear	NULL
JunB	NULL
protein	NULL
.	NULL

It	NULL
is	NULL
currently	NULL
accepted	NULL
that	NULL
the	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
is	NULL
responsible	NULL
for	NULL
its	NULL
electrophoretic	NULL
retardation	NULL
from	NULL
39	NULL
kDa	NULL
to	NULL
46	NULL
kDa	NULL
(	NULL
42	NULL
)	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
define	NULL
the	NULL
phosphorylated	NULL
status	NULL
of	NULL
the	NULL
nuclear	NULL
IL-6-translocated	NULL
JunB	NULL
protein	NULL
,	NULL
we	NULL
have	NULL
compared	NULL
the	NULL
migration	NULL
pattern	NULL
of	NULL
the	NULL
protein	NULL
present	NULL
in	NULL
7TD1	NULL
nuclear	NULL
extracts	NULL
with	NULL
that	NULL
of	NULL
a	NULL
nonphosphorylated	NULL
bacterially	NULL
expressed	NULL
fusion	NULL
protein	NULL
.	NULL

Lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
Panel	NULL
B	NULL
represented	NULL
the	NULL
stimulation	NULL
by	NULL
IL-6	NULL
of	NULL
the	NULL
nuclear	NULL
JunB	NULL
protein	NULL
.	NULL

As	NULL
indicated	NULL
,	NULL
JunB	NULL
migrated	NULL
as	NULL
an	NULL
unique	NULL
band	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
46	NULL
kDa	NULL
slightly	NULL
higher	NULL
than	NULL
the	NULL
bacterially	NULL
expressed	NULL
protein	NULL
(	NULL
39-40	NULL
kDa	NULL
)	NULL
(	NULL
lane	NULL
3	NULL
versus	NULL
lane	NULL
4	NULL
)	NULL
suggesting	NULL
,	NULL
by	NULL
analogy	NULL
with	NULL
results	NULL
observed	NULL
on	NULL
c-Jun	NULL
,	NULL
that	NULL
IL-6	NULL
might	NULL
stimulate	NULL
the	NULL
nuclear	NULL
trans-location	NULL
of	NULL
a	NULL
phosphorylated	NULL
form	NULL
of	NULL
JunB	NULL
.	NULL

IL-6	NULL
Stimulates	NULL
junB	NULL
Transcription	NULL
in	NULL
a	NULL
Biphasic	NULL
Manner-To	NULL
gain	NULL
information	NULL
on	NULL
the	NULL
way	NULL
IL-6	NULL
elicits	NULL
the	NULL
in	NULL
1263	NULL
A	NULL
8	NULL
§	NULL
``	NULL
I	NULL
Bg	NULL
o	NULL
junB	NULL
5	NULL
o	NULL
®	NULL
c-myc	NULL
0	NULL
C	NULL
$	NULL
3	NULL
'|	NULL
-	NULL
<	NULL
o	NULL
C	NULL
0	NULL
G	NULL
2	NULL
k	NULL
0	NULL
.	NULL

0	NULL
5	NULL
10	NULL
B	NULL
Time	NULL
(	NULL
Hrs	NULL
)	NULL
junB	NULL
|	NULL
|	NULL
|	NULL
|	NULL
|	NULL
0	NULL
-	NULL
+e	NULL
>	NULL
IL-6	NULL
0	NULL
0.5	NULL
2	NULL
5	NULL
6	NULL
10	NULL
C	NULL
c-myc	NULL
IL-6	NULL
_	NULL
0	NULL
0.5	NULL
5	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Transcriptional	NULL
induction	NULL
of	NULL
junB	NULL
and	NULL
c-mye	NULL
genes	NULL
in	NULL
isolated	NULL
nuclei	NULL
of	NULL
7TD1	NULL
cells	NULL
exposed	NULL
to	NULL
IL-6	NULL
.	NULL

Quiescent	NULL
7TD1	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
IL-6	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
[	NULL
a-*P	NULL
]	NULL
JUTP	NULL
was	NULL
incorporated	NULL
into	NULL
nascent	NULL
RNA	NULL
chains	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Labeled	NULL
RNA	NULL
(	NULL
10	NULL
``	NULL
cpm	NULL
)	NULL
was	NULL
then	NULL
hybridized	NULL
for	NULL
48	NULL
h	NULL
to	NULL
5	NULL
ug	NULL
of	NULL
jun	NULL
B	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
or	NULL
e-mye	NULL
cDNA	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
immobilized	NULL
on	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
filters	NULL
were	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
for	NULL
1	NULL
day	NULL
.	NULL

Panel	NULL
A	NULL
represents	NULL
the	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
autoradiograms	NULL
hybridized	NULL
with	NULL
jun	NULL
B	NULL
(	NULL
]	NULL
)	NULL
and	NULL
c-myc	NULL
(	NULL
EI	NULL
)	NULL
cDNAs	NULL
,	NULL
respectively	NULL
.	NULL

crease	NULL
of	NULL
the	NULL
two	NULL
jun	NULL
B	NULL
mRNA	NULL
peaks	NULL
,	NULL
run-on	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
first	NULL
determine	NULL
whether	NULL
IL-6	NULL
controlled	NULL
the	NULL
transcriptional	NULL
rate	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

Nascent	NULL
nuclear	NULL
RNA	NULL
chains	NULL
,	NULL
biosynthetically	NULL
labeled	NULL
with	NULL
[	NULL
a-°P	NULL
]	NULL
UTP	NULL
,	NULL
were	NULL
isolated	NULL
from	NULL
7TD1	NULL
cells	NULL
stimulated	NULL
for	NULL
0	NULL
to	NULL
10	NULL
h	NULL
with	NULL
IL-6	NULL
and	NULL
used	NULL
to	NULL
hybridize	NULL
nitrocellulose	NULL
filters	NULL
previously	NULL
spotted	NULL
with	NULL
plas-mids	NULL
containing	NULL
either	NULL
c-myc	NULL
or	NULL
jun	NULL
B	NULL
inserts	NULL
.	NULL

Results	NULL
concerning	NULL
junB	NULL
transcription	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
panel	NULL
B	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
30	NULL
)	NULL
,	NULL
a	NULL
very	NULL
low	NULL
but	NULL
detectable	NULL
constitutive	NULL
level	NULL
of	NULL
junrB	NULL
transcription	NULL
was	NULL
measurable	NULL
in	NULL
7TTD1	NULL
cells	NULL
deprived	NULL
of	NULL
IL-6	NULL
for	NULL
24	NULL
h.	NULL
After	NULL
the	NULL
addition	NULL
of	NULL
IL-6	NULL
,	NULL
junB	NULL
transcripts	NULL
increased	NULL
abruptly	NULL
to	NULL
reach	NULL
a	NULL
maximal	NULL
value	NULL
at	NULL
30-60	NULL
min	NULL
,	NULL
before	NULL
declining	NULL
to	NULL
the	NULL
basal	NULL
value	NULL
by	NULL
2-3	NULL
h.	NULL
Interestingly	NULL
,	NULL
the	NULL
transcription	NULL
resumed	NULL
after	NULL
5	NULL
h	NULL
and	NULL
peaked	NULL
at	NULL
6	NULL
h	NULL
,	NULL
before	NULL
declining	NULL
again	NULL
by	NULL
8-9	NULL
h.	NULL
The	NULL
stimulatory	NULL
factors	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
scanning	NULL
the	NULL
spots	NULL
corresponding	NULL
to	NULL
the	NULL
neo-synthesized	NULL
junB	NULL
transcripts	NULL
,	NULL
were	NULL
,	NULL
respectively	NULL
,	NULL
8-fold	NULL
for	NULL
the	NULL
early	NULL
peak	NULL
(	NULL
maximum	NULL
at	NULL
30	NULL
min	NULL
)	NULL
and	NULL
4-fold	NULL
for	NULL
the	NULL
second	NULL
peak	NULL
(	NULL
maximum	NULL
at	NULL
6	NULL
h	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

The	NULL
biphasic	NULL
time	NULL
course	NULL
of	NULL
the	NULL
burst	NULL
in	NULL
the	NULL
transcription	NULL
rate	NULL
is	NULL
an	NULL
original	NULL
feature	NULL
that	NULL
probably	NULL
accounts	NULL
for	NULL
the	NULL
immediate	NULL
and	NULL
delayed	NULL
increase	NULL
in	NULL
junB	NULL
mRNA	NULL
levels	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
junB	NULL
transcription	NULL
,	NULL
e-mye	NULL
gene	NULL
was	NULL
constitutively	NULL
transcribed	NULL
in	NULL
noninduced	NULL
7TD1	NULL
cells	NULL
and	NULL
was	NULL
not	NULL
further	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
panel	NULL
C	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
biphasic	NULL
transcription	NULL
burst	NULL
,	NULL
described	NULL
here	NULL
,	NULL
is	NULL
not	NULL
a	NULL
general	NULL
IL-6-mediated	NULL
phenomena	NULL
since	NULL
it	NULL
does	NULL
not	NULL
concern	NULL
other	NULL
genes	NULL
like	NULL
c-myc	NULL
.	NULL

1264	NULL
A	NULL
6	NULL
c	NULL
$	NULL
_	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
IL-6	NULL
on	NULL
the	NULL
stability	NULL
1	NULL
%	NULL
*	NULL
of	NULL
the	NULL
early	NULL
junB	NULL
mRNA	NULL
peak	NULL
.	NULL

Quies-	NULL
g	NULL
4	NULL
cent	NULL
7TD1	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-6	NULL
E2	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
the	NULL
level	NULL
of	NULL
junB	NULL
mRNA	NULL
was	NULL
a	NULL
~	NULL
2	NULL
measured	NULL
during	NULL
the	NULL
next	NULL
3	NULL
h	NULL
,	NULL
by	NULL
North-	NULL
4	NULL
ern	NULL
blot	NULL
analysis	NULL
,	NULL
either	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
or	NULL
after	NULL
the	NULL
transcription	NULL
0	NULL
was	NULL
blocked	NULL
by	NULL
:	NULL
IL-6	NULL
withdrawal	NULL
(	NULL
panel	NULL
1	NULL
C	NULL
)	NULL
,	NULL
actinomycin	NULL
D	NULL
addition	NULL
(	NULL
panel	NULL
D	NULL
)	NULL
,	NULL
or	NULL
both	NULL
IL-6	NULL
removal	NULL
and	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
panel	NULL
E	NULL
)	NULL
.	NULL

On	NULL
panel	NULL
A	NULL
are	NULL
represented	NULL
the	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
Northern	NULL
blot	NULL
analysis	NULL
presented	NULL
in	NULL
panels	NULL
B	NULL
,	NULL
C	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E	NULL
,	NULL
referred	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
[	NULL
]	NULL
,	NULL
M	NULL
,	NULL
O	NULL
,	NULL
and	NULL
@	NULL
.	NULL

IL-6	NULL
Does	NULL
Not	NULL
Modify	NULL
the	NULL
Stability	NULL
of	NULL
junB	NULL
mRNA-In	NULL
order	NULL
to	NULL
further	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
IL-6	NULL
on	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
two	NULL
waves	NULL
of	NULL
junB	NULL
mRNA	NULL
,	NULL
7TD1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IL-6	NULL
(	NULL
100	NULL
units/ml	NULL
=	NULL
500	NULL
pg/ml	NULL
!	NULL
)	NULL

for	NULL
1	NULL
or	NULL
6	NULL
h	NULL
,	NULL
then	NULL
exposed	NULL
to	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
.	NULL

The	NULL
decay	NULL
of	NULL
RNA	NULL
was	NULL
followed	NULL
afterward	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
or	NULL
after	NULL
withdrawal	NULL
of	NULL
the	NULL
cytokine	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
panels	NULL
B	NULL
,	NULL
C	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E	NULL
(	NULL
early	NULL
peak	NULL
)	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
panels	NULL
B	NULL
,	NULL
C	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E	NULL
(	NULL
late	NULL
peak	NULL
)	NULL
.	NULL

The	NULL
corresponding	NULL
densitometric	NULL
RNA	NULL
level	NULL
quantifications	NULL
are	NULL
presented	NULL
in	NULL
panel	NULL
A	NULL
of	NULL
Figs	NULL
.	NULL

4	NULL
and	NULL
5	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytokine	NULL
or	NULL
actinomycin	NULL
D	NULL
,	NULL
the	NULL
first	NULL
burst	NULL
of	NULL
transcription	NULL
was	NULL
shut	NULL
off	NULL
after	NULL
60-90	NULL
min	NULL
,	NULL
and	NULL
junB	NULL
mRNA	NULL
decayed	NULL
with	NULL
the	NULL
same	NULL
half-life	NULL
(	NULL
about	NULL
40-50	NULL
min	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
IL-6	NULL
exclusively	NULL
controlled	NULL
the	NULL
transcription	NULL
step	NULL
without	NULL
any	NULL
modification	NULL
of	NULL
junB	NULL
mRNA	NULL
stability	NULL
.	NULL

When	NULL
the	NULL
transcription	NULL
was	NULL
blocked	NULL
by	NULL
actinomycin	NULL
D	NULL
,	NULL
6	NULL
h	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
IL-6	NULL
,	NULL
junB	NULL
mRNA	NULL
decayed	NULL
with	NULL
the	NULL
same	NULL
time	NULL
course	NULL
(	NULL
half-life	NULL
about	NULL
40	NULL
min	NULL
)	NULL
,	NULL
whatever	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-6	NULL
in	NULL
the	NULL
medium	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
panels	NULL
D	NULL
and	NULL
E	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
IL-6	NULL
did	NULL
not	NULL
control	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
second	NULL
peak	NULL
of	NULL
junB	NULL
mRNA	NULL
.	NULL

Concerning	NULL
the	NULL
second	NULL
wave	NULL
of	NULL
junB	NULL
transcription	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
to	NULL
notice	NULL
that	NULL
as	NULL
soon	NULL
as	NULL
IL-6	NULL
was	NULL
removed	NULL
junB	NULL
mRNA	NULL
decayed	NULL
rapidly	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
panel	NULL
C	NULL
)	NULL
indicating	NULL
that	NULL
IL-6	NULL
withdrawal	NULL
led	NULL
to	NULL
a	NULL
rapid	NULL
arrest	NULL
of	NULL
jun	NULL
B	NULL
transcription	NULL
.	NULL

Thus	NULL
,	NULL
at	NULL
variance	NULL
with	NULL
the	NULL
first	NULL
peak	NULL
of	NULL
junB	NULL
RNA	NULL
,	NULL
IL-6	NULL
was	NULL
permanently	NULL
required	NULL
to	NULL
sustain	NULL
jun	NULL
B	NULL
transcription	NULL
during	NULL
the	NULL
second	NULL
wave	NULL
.	NULL

Cycloheximide	NULL
Potentiated	NULL
the	NULL
Effect	NULL
of	NULL
IL-6	NULL
on	NULL
the	NULL
Second	NULL
but	NULL
Not	NULL
on	NULL
the	NULL
First	NULL
junB	NULL
mRNA	NULL
Peak-Studies	NULL
were	NULL
carried	NULL
out	NULL
to	NULL
investigate	NULL
whether	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
might	NULL
influence	NULL
the	NULL
early	NULL
and/or	NULL
late	NULL
junB	NULL
transcription	NULL
and	NULL
mRNA	NULL
stability	NULL
.	NULL

Quiescent	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-6	NULL
for	NULL
1	NULL
or	NULL
6	NULL
h	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
cycloheximide	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
after	NULL
which	NULL
the	NULL
junB	NULL
transcription	NULL
and	NULL
mRNA	NULL
level	NULL
were	NULL
followed	NULL
for	NULL
4	NULL
h.	NULL
The	NULL
results	NULL
demonstrated	NULL
that	NULL
the	NULL
level	NULL
of	NULL
the	NULL
early-induced	NULL
junB	NULL
mRNA	NULL
was	NULL
identical	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
cycloheximide	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
panel	NULL
B	NULL
,	NULL
when	NULL
the	NULL
transcription	NULL
was	NULL
blocked	NULL
by	NULL
actinomycin	NULL
D	NULL
,	NULL
cycloheximide	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
time	NULL
course	NULL
of	NULL
junB	NULL
mRNA	NULL
decay	NULL
(	NULL
about	NULL
40	NULL
min	NULL
as	NULL
estimated	NULL
by	NULL
quantitating	NULL
the	NULL
RNA	NULL
level	NULL
by	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
autoradiogram	NULL
,	NULL
panel	NULL
A	NULL
)	NULL
suggesting	NULL
that	NULL
protein	NULL
synthesis	NULL
is	NULL
neither	NULL
required	NULL
for	NULL
the	NULL
synthesis	NULL
nor	NULL
for	NULL
Effect	NULL
of	NULL
IL-6	NULL
on	NULL
junB	NULL
Transcription	NULL
and	NULL
Synthesis	NULL
O	NULL
+1L-6	NULL
E	NULL
-iL-6	NULL
O	NULL
+1-6	NULL
+	NULL
acrp	NULL
C	NULL
@	NULL
-	NULL
IL-6	NULL
+	NULL
Act	NULL
.	NULL

D	NULL
Time	NULL
(	NULL
Hrs	NULL
)	NULL
.	NULL

®	NULL
+	NULL
IL-6	NULL
1.5	NULL
+	NULL
Act.D	NULL
«	NULL
IL-6	NULL
-	NULL
1.5	NULL
2	NULL
2.5	NULL
3	NULL
4	NULL
5	NULL
2	NULL
2.	NULL
waw	NULL
+	NULL
Act.D	NULL
the	NULL
degradation	NULL
phases	NULL
of	NULL
this	NULL
rapid	NULL
junB	NULL
mRNA	NULL
wave	NULL
.	NULL

In	NULL
a	NULL
parallel	NULL
run-on	NULL
experiment	NULL
,	NULL
we	NULL
also	NULL
demonstrated	NULL
that	NULL
cycloheximide	NULL
did	NULL
not	NULL
modify	NULL
early	NULL
IL-6-induced	NULL
jun	NULL
B	NULL
transcription	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
observation	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
results	NULL
from	NULL
Nakajima	NULL
and	NULL
Wall	NULL
(	NULL
30	NULL
)	NULL
on	NULL
the	NULL
MH6O	NULL
BSF-2	NULL
cell	NULL
line	NULL
.	NULL

At	NULL
variance	NULL
,	NULL
it	NULL
differs	NULL
from	NULL
the	NULL
results	NULL
obtained	NULL
by	NULL
Lord	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
on	NULL
the	NULL
myeloid	NULL
cell	NULL
line	NULL
M1	NULL
.	NULL

On	NULL
this	NULL
model	NULL
,	NULL
these	NULL
authors	NULL
demonstrated	NULL
that	NULL
cycloheximide	NULL
stabilized	NULL
junB	NULL
mRNA	NULL
by	NULL
decreasing	NULL
its	NULL
degradation	NULL
.	NULL

The	NULL
situation	NULL
was	NULL
different	NULL
when	NULL
we	NULL
looked	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
cycloheximide	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
second	NULL
jun	NULL
B	NULL
mRNA	NULL
wave	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
,	NULL
the	NULL
level	NULL
of	NULL
the	NULL
late-induced	NULL
jun	NULL
B	NULL
mRNA	NULL
measured	NULL
after	NULL
6	NULL
h	NULL
of	NULL
IL-6	NULL
was	NULL
15-20-fold	NULL
higher	NULL
than	NULL
that	NULL
measured	NULL
without	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

To	NULL
approach	NULL
the	NULL
mechanism	NULL
of	NULL
this	NULL
superin-duction	NULL
,	NULL
we	NULL
measured	NULL
IL-6-stimulated	NULL
junB	NULL
transcription	NULL
by	NULL
run-on	NULL
experiments	NULL
,	NULL
after	NULL
exposure	NULL
for	NULL
6	NULL
and	NULL
8	NULL
h	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
IL-6	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ug/ml	NULL
cyclohexi-mide	NULL
.	NULL

Clearly	NULL
,	NULL
cycloheximide	NULL
potentiated	NULL
the	NULL
IL-6-stimulated	NULL
junB	NULL
transcription	NULL
rate	NULL
to	NULL
an	NULL
extent	NULL
that	NULL
matched	NULL
mRNA	NULL
accumulation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
a	NULL
possible	NULL
combined	NULL
effect	NULL
of	NULL
cycloheximide	NULL
and	NULL
actinomycin	NULL
D	NULL
on	NULL
jun	NULL
B	NULL
mRNA	NULL
stability	NULL
,	NULL
we	NULL
blocked	NULL
cellular	NULL
transcription	NULL
with	NULL
actinomycin	NULL
D	NULL
,	NULL
6	NULL
h	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
IL-6	NULL
and	NULL
cycloheximide	NULL
,	NULL
and	NULL
measured	NULL
jun	NULL
B	NULL
mRNA	NULL
decay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
panel	NULL
C	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
time	NULL
course	NULL
of	NULL
junB	NULL
mRNA	NULL
shut-off	NULL
,	NULL
determined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
and	NULL
quantified	NULL
by	NULL
densitometric	NULL
scanning	NULL
(	NULL
right	NULL
part	NULL
of	NULL
panel	NULL
C	NULL
)	NULL
,	NULL
was	NULL
not	NULL
modified	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
,	NULL
compared	NULL
to	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
panel	NULL
D	NULL
,	NULL
confirming	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
drug	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
sole	NULL
increase	NULL
of	NULL
the	NULL
junB	NULL
transcription	NULL
rate	NULL
and	NULL
did	NULL
not	NULL
lie	NULL
on	NULL
increased	NULL
junB	NULL
mRNA	NULL
stability	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
results	NULL
obtained	NULL
on	NULL
junB	NULL
mRNA	NULL
,	NULL
cycloheximide	NULL
does	NULL
not	NULL
potentiate	NULL
but	NULL
rather	NULL
inhibits	NULL
e-mye	NULL
mRNA	NULL
expression	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Tyrphostin	NULL
and	NULL
Genistein	NULL
Inhibited	NULL
,	NULL
Respectively	NULL
,	NULL
the	NULL
Early-and	NULL
the	NULL
Late-induced	NULL
junB	NULL
mRNA	NULL
Wave-As	NULL
described	NULL
by	NULL
others	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
,	NULL
induction	NULL
by	NULL
IL-6	NULL
of	NULL
the	NULL
early	NULL
junB	NULL
mRNA	NULL
requires	NULL
activation	NULL
of	NULL
tyrosine	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
.	NULL

However	NULL
,	NULL
to	NULL
date	NULL
,	NULL
no	NULL
study	NULL
has	NULL
been	NULL
reported	NULL
concerning	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
late-induced	NULL
junB	NULL
mRNA	NULL
level	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
clarify	NULL
this	NULL
question	NULL
,	NULL
we	NULL
have	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
one	NULL
of	NULL
the	NULL
tyrphostins	NULL
(	NULL
25	NULL
,	NULL
RG50875	NULL
)	NULL
and	NULL
of	NULL
genistein	NULL
,	NULL
two	NULL
potent	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
,	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
both	NULL
early-	NULL
and	NULL
late-induced	NULL
jun	NULL
B	NULL
mRNA	NULL
in	NULL
7TD1	NULL
Effect	NULL
of	NULL
IL-6	NULL
on	NULL
junB	NULL
Transcription	NULL
and	NULL
Synthesis	NULL
1265	NULL
A	NULL
B	NULL
8	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
IL-6	NULL
on	NULL
the	NULL
stability	NULL
o	NULL
6	NULL
-O-of	NULL
the	NULL
late-induced	NULL
jun	NULL
B	NULL
mRNA	NULL
wave	NULL
.	NULL

#	NULL
/	NULL
+IL-6	NULL
-	NULL
0	NULL
-	NULL
6	NULL
-	NULL
7	NULL
-	NULL
8	NULL
9	NULL
This	NULL
experiment	NULL
has	NULL
been	NULL
carried	NULL
out	NULL
in	NULL
I	NULL
2	NULL
C	NULL
1	NULL
iL-6	NULL
the	NULL
same	NULL
condltlpns	NULL
as	NULL
in	NULL
Elg	NULL
.	NULL

4	NULL
,	NULL
except	NULL
‘	NULL
E	NULL
g	NULL
*	NULL
M	NULL
causes	NULL
C	NULL
a	NULL
that	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-6	NULL
for	NULL
6	NULL
hei	NULL
O	NULL
+	NULL
IL-6	NULL
+	NULL
ActD	NULL
to	NULL
h	NULL
instead	NULL
of	NULL
1	NULL
h.	NULL
On	NULL
panel	NULL
B	NULL
is	NULL
depicted	NULL
5	NULL
o	NULL
|	NULL
the	NULL
level	NULL
of	NULL
junB	NULL
mRNA	NULL
,	NULL
determined	NULL
by	NULL
e	NULL
~IEG	NULL
#	NULL
AsLD	NULL
--	NULL
®	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
between	NULL
6	NULL
and	NULL
9	NULL
h	NULL
~IL-6	NULL
_	NULL
7	NULL
8	NULL
9	NULL
_	NULL
10	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
.	NULL

Panels	NULL
C	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E	NULL
D	NULL
show	NULL
the	NULL
level	NULL
of	NULL
IL-6-induced	NULL
junB	NULL
0	NULL
mRNA	NULL
after	NULL
the	NULL
transcription	NULL
was	NULL
L	NULL
1	NULL
£	NULL
1	NULL
i	NULL
.	NULL

blocked	NULL
by	NULL
:	NULL
IL-6	NULL
withdrawal	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
,	NULL
ac-	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
tinomycin	NULL
D	NULL
addition	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
(	NULL
panel	NULL
D	NULL
)	NULL
,	NULL
Time	NULL
(	NULL
Hrs	NULL
)	NULL
-o-or	NULL
both	NULL
(	NULL
panel	NULL
E	NULL
)	NULL
.	NULL

Panel	NULL
A	NULL
shows	NULL
densito-	NULL
+	NULL
IL-6	NULL
s	NULL
9	NULL
40	NULL
metric	NULL
scanning	NULL
of	NULL
Northern	NULL
blots	NULL
shown	NULL
+	NULL
Act.D	NULL
in	NULL
panels	NULL
B	NULL
,	NULL
C	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E.	NULL
The	NULL
symbols	NULL
[	NULL
]	NULL
,	NULL
E	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
®	NULL
correspond	NULL
,	NULL
respectively	NULL
,	NULL
to	NULL
panels	NULL
B	NULL
,	NULL
C	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E.	NULL
f	NULL
“	NULL
?	NULL

-e	NULL
--	NULL
IL-6	NULL
+	NULL
Act.D	NULL
T	NULL
8	NULL
.	NULL

#	NULL
10	NULL
A	NULL
A	NULL
B	NULL
s	NULL
_	NULL
10	NULL
10	NULL
&	NULL
g	NULL
s	NULL
<	NULL
o	NULL
282	NULL
s	NULL
*	NULL
0	NULL
0	NULL
0	NULL
7.6	NULL
as	NULL
2	NULL
.	NULL

~~	NULL
6-	NULL
&	NULL
o	NULL
I	NULL
o	NULL
@	NULL
n	NULL
f	NULL
P-	NULL
&	NULL
£	NULL
2	NULL
%	NULL
;	NULL
1	NULL
$	NULL
fo	NULL
if	NULL
i	NULL
$	NULL
f	NULL
CC	NULL
+	NULL
2	NULL
3	NULL
@	NULL
®	NULL
o=	NULL
5	NULL
6	NULL
<	NULL
=	NULL
+	NULL
+	NULL
ti	NULL
~	NULL
i	NULL
©	NULL
§	NULL
2.5	NULL
e	NULL
3	NULL
6	NULL
10	NULL
o	NULL
4	NULL
,	NULL
j	NULL
4	NULL
f	NULL
j	NULL
U	NULL
®	NULL
:	NULL
:	NULL
1	NULL
1.5	NULL
2	NULL
2.6	NULL
3	NULL
8	NULL
_	NULL
Time	NULL
(	NULL
Hrs	NULL
)	NULL
~	NULL
&	NULL
~-	NULL
S	NULL
y	NULL
6	NULL
Ike	NULL
_	NULL
s	NULL
80	NULL
0	NULL
9	NULL
00	NULL
E*	NULL
B	NULL
+	NULL
CHX	NULL
E3	NULL
4	NULL
m	NULL
S	NULL
§	NULL
.	NULL

>	NULL
00	NULL
@	NULL
-	NULL
++	NULL
s	NULL
ud	NULL
®	NULL
R	NULL
-	NULL
#	NULL
-	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
IL-6	NULL
+	NULL
CHX	NULL
7	NULL
8	NULL
9	NULL
Time	NULL
(	NULL
Hrs	NULL
)	NULL
IL-6	NULL
+	NULL
CHX	NULL
10	NULL
1.5002	NULL
0003	NULL
+	NULL
Act.D	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
cycloheximide	NULL
on	NULL
the	NULL
late	NULL
IL-6-induced	NULL
junB	NULL
mRNA	NULL
wave	NULL
.	NULL

The	NULL
figure	NULL
represents	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
second	NULL
peaks	NULL
of	NULL
:	NULL
junB	NULL
mRNA	NULL
(	NULL
densitometric	NULL
scanning	NULL
of	NULL
an	NULL
overnight	NULL
exposed	NULL
autora-	NULL
.	NULL

5	NULL
%	NULL
diogram	NULL
)	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
and	NULL
junB	NULL
transcription	NULL
(	NULL
autoradiogram	NULL
exposed	NULL
for	NULL
f	NULL
24	NULL
h	NULL
at	NULL
-80	NULL
°C	NULL
)	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
stimulated	NULL
by	NULL
IL-6	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
cycloheximide	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

On	NULL
panel	NULL
C	NULL
is	NULL
shown	NULL
the	NULL
effect	NULL
of	NULL
cyclohex-	NULL
#	NULL
imide	NULL
on	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
late-induced	NULL
junB	NULL
mRNA	NULL
wave	NULL
.	NULL

In	NULL
each	NULL
IL-6	NULL
+	NULL
CHX	NULL
1.5	NULL
2	NULL
2.5	NULL
3	NULL
experiment	NULL
,	NULL
7TD1	NULL
cells	NULL
were	NULL
first	NULL
stimulated	NULL
with	NULL
IL-6	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
.	NULL

+	NULL
Act.D	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
cycloheximide	NULL
on	NULL
the	NULL
early-induced	NULL
junB	NULL
mRNA	NULL
peak	NULL
.	NULL

Quiescent	NULL
7TD1	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
cycloheximide	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
stimulated	NULL
with	NULL
IL-6	NULL
for	NULL
1	NULL
h	NULL
,	NULL
then	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
]	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
®	NULL
)	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
total	NULL
RNAs	NULL
were	NULL
extracted	NULL
and	NULL
the	NULL
level	NULL
of	NULL
junB	NULL
mRNA	NULL
was	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
nitrocelluloses	NULL
were	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
for	NULL
24	NULL
h	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

Panel	NULL
A	NULL
shows	NULL
densitometric	NULL
scanning	NULL
of	NULL
Northern	NULL
blot	NULL
analysis	NULL
shown	NULL
in	NULL
panel	NULL
B.	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
7TD1	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
tyrphostin	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
or	NULL
genistein	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
then	NULL
IL-6	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
was	NULL
added	NULL
and	NULL
the	NULL
level	NULL
of	NULL
junB	NULL
mRNA	NULL
was	NULL
followed	NULL
for	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
6	NULL
h.	NULL
As	NULL
expected	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
,	NULL
tyrphostin	NULL
25	NULL
inhibited	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
early	NULL
junB	NULL
mRNA	NULL
by	NULL
greater	NULL
than	NULL
90-95	NULL
%	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
but	NULL
surprisingly	NULL
,	NULL
did	NULL
not	NULL
block	NULL
the	NULL
After	NULL
3	NULL
h	NULL
,	NULL
cycloheximide	NULL
was	NULL
added	NULL
and	NULL
the	NULL
incubation	NULL
was	NULL
pursued	NULL
for	NULL
an	NULL
additional	NULL
3	NULL
h	NULL
,	NULL
then	NULL
the	NULL
levels	NULL
of	NULL
junrB	NULL
transcription	NULL
and	NULL
mRNA	NULL
were	NULL
estimated	NULL
by	NULL
run-on	NULL
experiment	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

To	NULL
investigate	NULL
the	NULL
effect	NULL
of	NULL
cycloheximide	NULL
on	NULL
jun	NULL
B	NULL
mRNA	NULL
stability	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
,	NULL
by	NULL
IL-6	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
,	NULL
according	NULL
to	NULL
the	NULL
procedure	NULL
described	NULL
above	NULL
,	NULL
then	NULL
actinomycin	NULL
was	NULL
added	NULL
(	NULL
MW	NULL
)	NULL
or	NULL
not	NULL
(	NULL
)	NULL
)	NULL
,	NULL
and	NULL
the	NULL
level	NULL
of	NULL
junB	NULL
mRNA	NULL
was	NULL
measured	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
figure	NULL
represents	NULL
autoradiograms	NULL
exposed	NULL
for	NULL
24	NULL
h	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

The	NULL
right	NULL
part	NULL
of	NULL
panel	NULL
C	NULL
represents	NULL
the	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
Northern	NULL
blots	NULL
obtained	NULL
from	NULL
7TD1	NULL
cells	NULL
incubated	NULL
between	NULL
6	NULL
and	NULL
9	NULL
h	NULL
with	NULL
:	NULL
IL-6	NULL
plus	NULL
cycloheximide	NULL
(	NULL
]	NULL
)	NULL
or	NULL
IL-6	NULL
plus	NULL
cycloheximide	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
®	NULL
)	NULL
.	NULL

stimulation	NULL
of	NULL
the	NULL
late-induced	NULL
junB	NULL
expression	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
tyrphostin-sensitive	NULL
tyrosine	NULL
kinase	NULL
controls	NULL
the	NULL
first	NULL
junB	NULL
mRNA	NULL
wave	NULL
.	NULL

At	NULL
variance	NULL
with	NULL
results	NULL
published	NULL
by	NULL
Nakajima	NULL
and	NULL
Wall	NULL
(	NULL
30	NULL
)	NULL
,	NULL
genistein	NULL
,	NULL
another	NULL
tyrosine	NULL
kinase	NULL
1266	NULL
<	NULL
€18S	NULL
<	NULL
<	NULL
18S	NULL
junB	NULL
»	NULL
<	NULL
18S	NULL
IL-6	NULL
+	NULL
Tyrph	NULL
.	NULL

Fic	NULL
.	NULL

8	NULL
.	NULL

Effect	NULL
of	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
on	NULL
junB	NULL
mRNA	NULL
stimulated	NULL
by	NULL
IL-6	NULL
.	NULL

Quiescent	NULL
7TD1	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
either	NULL
genistein	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
or	NULL
tyrphostin	NULL
25	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
and	NULL
stimulated	NULL
with	NULL
IL-6	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
for	NULL
,	NULL
respectively	NULL
,	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
6	NULL
h.	NULL
Total	NULL
RNAs	NULL
were	NULL
purified	NULL
,	NULL
separated	NULL
on	NULL
agarose	NULL
gels	NULL
,	NULL
blotted	NULL
onto	NULL
nylon	NULL
membrane	NULL
,	NULL
and	NULL
finally	NULL
hybridized	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
``	NULL
with	NULL
*°P-labeled	NULL
cDNA	NULL
probe	NULL
encoding	NULL
for	NULL
junB	NULL
(	NULL
left	NULL
part	NULL
)	NULL
.	NULL

On	NULL
the	NULL
right	NULL
part	NULL
is	NULL
shown	NULL
the	NULL
level	NULL
of	NULL
ribosomal	NULL
18	NULL
S	NULL
RNA	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
as	NULL
a	NULL
control	NULL
of	NULL
RNA	NULL
loading	NULL
.	NULL

inhibitor	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
early-induced	NULL
jurnB	NULL
mRNA	NULL
peak	NULL
but	NULL
,	NULL
interestingly	NULL
,	NULL
abolished	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
second	NULL
wave	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
similarly	NULL
to	NULL
the	NULL
early-induced	NULL
peak	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
delayed	NULL
junB	NULL
mRNA	NULL
also	NULL
required	NULL
activation	NULL
of	NULL
a	NULL
tyrosine	NULL
kinase	NULL
.	NULL

Taking	NULL
together	NULL
the	NULL
present	NULL
results	NULL
suggested	NULL
that	NULL
IL-6	NULL
triggered	NULL
two	NULL
distinct	NULL
tyrosine	NULL
kinase	NULL
activities	NULL
that	NULL
controlled	NULL
expression	NULL
of	NULL
the	NULL
early-	NULL
and	NULL
late-induced	NULL
junB	NULL
mRNA	NULL
,	NULL
respectively	NULL
.	NULL

DISCUSSION	NULL
Interleukin-6	NULL
is	NULL
responsible	NULL
for	NULL
various	NULL
biological	NULL
effects	NULL
such	NULL
as	NULL
inflammation	NULL
and	NULL
growth	NULL
of	NULL
myeloma	NULL
or	NULL
hybridoma	NULL
cells	NULL
.	NULL

To	NULL
date	NULL
,	NULL
the	NULL
mechanisms	NULL
underlying	NULL
IL-6	NULL
effects	NULL
are	NULL
a	NULL
matter	NULL
of	NULL
intense	NULL
research	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
gain	NULL
information	NULL
on	NULL
molecular	NULL
events	NULL
involved	NULL
in	NULL
IL-6	NULL
mitogenic	NULL
action	NULL
,	NULL
we	NULL
have	NULL
used	NULL
the	NULL
mouse	NULL
B	NULL
hybridoma	NULL
cell	NULL
line	NULL
7TD1	NULL
,	NULL
which	NULL
is	NULL
IL-6-dependent	NULL
for	NULL
survival	NULL
and	NULL
proliferation	NULL
,	NULL
and	NULL
studied	NULL
the	NULL
regulation	NULL
by	NULL
this	NULL
cytokine	NULL
of	NULL
junB	NULL
,	NULL
a	NULL
cellular	NULL
oncogene	NULL
acknowledged	NULL
to	NULL
be	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
growth	NULL
(	NULL
43-45	NULL
)	NULL
.	NULL

junB	NULL
is	NULL
a	NULL
typical	NULL
early	NULL
and	NULL
transiently	NULL
activated	NULL
oncogene	NULL
,	NULL
inducible	NULL
by	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
stimuli	NULL
that	NULL
elicit	NULL
diverse	NULL
biological	NULL
functions	NULL
(	NULL
29	NULL
,	NULL
30	NULL
,	NULL
39	NULL
,	NULL
46-48	NULL
)	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
,	NULL
in	NULL
7TTD1	NULL
cells	NULL
,	NULL
IL-6	NULL
stimulated	NULL
junrB	NULL
mRNA	NULL
in	NULL
a	NULL
biphasic	NULL
fashion	NULL
.	NULL

The	NULL
first	NULL
peak	NULL
presented	NULL
a	NULL
sharply	NULL
transient	NULL
aspect	NULL
while	NULL
the	NULL
second	NULL
rise	NULL
in	NULL
junB	NULL
mRNA	NULL
was	NULL
more	NULL
sustained	NULL
.	NULL

The	NULL
IL-6	NULL
effect	NULL
was	NULL
specific	NULL
of	NULL
junB	NULL
,	NULL
since	NULL
c-myc	NULL
that	NULL
was	NULL
constitutively	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
this	NULL
biological	NULL
model	NULL
was	NULL
not	NULL
further	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytokine	NULL
.	NULL

We	NULL
demonstrated	NULL
by	NULL
the	NULL
means	NULL
of	NULL
run-on	NULL
experiments	NULL
that	NULL
the	NULL
two	NULL
peaks	NULL
in	NULL
junB	NULL
mRNA	NULL
resulted	NULL
exclusively	NULL
,	NULL
in	NULL
both	NULL
cases	NULL
,	NULL
from	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
transcription	NULL
rate	NULL
,	NULL
without	NULL
any	NULL
effect	NULL
on	NULL
mRNA	NULL
stability	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
immediate	NULL
jun	NULL
B	NULL
mRNA	NULL
early	NULL
peak	NULL
culminated	NULL
at	NULL
30-60	NULL
min	NULL
and	NULL
rapidly	NULL
declined	NULL
to	NULL
the	NULL
basal	NULL
value	NULL
,	NULL
by	NULL
2	NULL
h.	NULL
It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
declining	NULL
phase	NULL
presented	NULL
the	NULL
same	NULL
time	NULL
course	NULL
regardless	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
in	NULL
the	NULL
medium	NULL
.	NULL

This	NULL
shut-off	NULL
mechanism	NULL
was	NULL
specific	NULL
for	NULL
junB	NULL
since	NULL
during	NULL
the	NULL
same	NULL
time	NULL
span	NULL
c-myc	NULL
transcription	NULL
remained	NULL
un-affected	NULL
.	NULL

Inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
by	NULL
cycloheximide	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
kinetic	NULL
profile	NULL
of	NULL
this	NULL
IL-6-induced	NULL
early	NULL
peak	NULL
of	NULL
Effect	NULL
of	NULL
IL-6	NULL
on	NULL
junB	NULL
Transcription	NULL
and	NULL
Synthesis	NULL
junB	NULL
mRNA	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
start	NULL
and	NULL
the	NULL
arrest	NULL
of	NULL
junB	NULL
transcription	NULL
during	NULL
this	NULL
process	NULL
were	NULL
not	NULL
dependent	NULL
on	NULL
the	NULL
synthesis	NULL
of	NULL
new	NULL
factors	NULL
,	NULL
but	NULL
rather	NULL
stem	NULL
from	NULL
post-translational	NULL
modifications	NULL
of	NULL
factors	NULL
pre-existing	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
cytokine	NULL
.	NULL

The	NULL
situation	NULL
observed	NULL
following	NULL
the	NULL
second	NULL
peak	NULL
of	NULL
junB	NULL
mRNA	NULL
was	NULL
different	NULL
in	NULL
the	NULL
sense	NULL
that	NULL
,	NULL
intriguingly	NULL
,	NULL
cycloheximide	NULL
strongly	NULL
potentiated	NULL
the	NULL
IL-6-stimulated	NULL
junB	NULL
transcription	NULL
rate	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
data	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
occurrence	NULL
of	NULL
a	NULL
constitutive	NULL
jun	NULL
B	NULL
transcriptional	NULL
repressor	NULL
which	NULL
specifically	NULL
regulates	NULL
the	NULL
second	NULL
wave	NULL
of	NULL
junB	NULL
mRNA	NULL
synthesis	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
in	NULL
accord	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
showing	NULL
a	NULL
superinduction	NULL
effect	NULL
of	NULL
cycloheximide	NULL
on	NULL
junB	NULL
under	NULL
fetal	NULL
calf	NULL
serum	NULL
or	NULL
growth	NULL
factor	NULL
,	NULL
like	NULL
fibroblast	NULL
growth	NULL
factor	NULL
or	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
,	NULL
stimulation	NULL
on	NULL
mouse	NULL
fibroblasts	NULL
(	NULL
39	NULL
,	NULL
47	NULL
)	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
such	NULL
a	NULL
repressor	NULL
was	NULL
only	NULL
detectable	NULL
during	NULL
the	NULL
onset	NULL
of	NULL
the	NULL
second	NULL
wave	NULL
of	NULL
transcription	NULL
which	NULL
would	NULL
mean	NULL
that	NULL
its	NULL
activation	NULL
requires	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
occurring	NULL
after	NULL
the	NULL
first	NULL
peak	NULL
of	NULL
junB	NULL
mRNA	NULL
.	NULL

As	NULL
demonstrated	NULL
by	NULL
the	NULL
experiments	NULL
using	NULL
actinomycin	NULL
D	NULL
,	NULL
the	NULL
prolonged	NULL
expression	NULL
of	NULL
junB	NULL
mRNA	NULL
during	NULL
the	NULL
second	NULL
phase	NULL
was	NULL
due	NULL
to	NULL
a	NULL
sustained	NULL
transcription	NULL
activity	NULL
that	NULL
was	NULL
itself	NULL
strictly	NULL
dependent	NULL
on	NULL
the	NULL
permanent	NULL
presence	NULL
of	NULL
IL-6	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
the	NULL
first	NULL
peak	NULL
's	NULL
features	NULL
,	NULL
no	NULL
deactivation	NULL
in	NULL
transcriptional	NULL
activity	NULL
was	NULL
observed	NULL
during	NULL
the	NULL
second	NULL
wave	NULL
of	NULL
transcripts	NULL
,	NULL
provided	NULL
that	NULL
IL-6	NULL
was	NULL
present	NULL
in	NULL
the	NULL
medium	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
declining	NULL
phase	NULL
that	NULL
occurred	NULL
after	NULL
8-9	NULL
h	NULL
did	NULL
not	NULL
result	NULL
from	NULL
an	NULL
IL-6-driven	NULL
deactivation	NULL
mechanism	NULL
,	NULL
but	NULL
rather	NULL
reflected	NULL
the	NULL
fact	NULL
that	NULL
cells	NULL
entered	NULL
into	NULL
S	NULL
phase	NULL
during	NULL
which	NULL
transcriptional	NULL
activity	NULL
is	NULL
largely	NULL
de-creased	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
addition	NULL
of	NULL
aphidicoline	NULL
that	NULL
impedes	NULL
cells	NULL
to	NULL
reinitiate	NULL
their	NULL
DNA	NULL
replication	NULL
program	NULL
maintained	NULL
the	NULL
maximal	NULL
level	NULL
of	NULL
junB	NULL
transcripts	NULL
during	NULL
the	NULL
second	NULL
peak	NULL
,	NULL
all	NULL
along	NULL
the	NULL
time	NULL
this	NULL
drug	NULL
was	NULL
present	NULL
in	NULL
the	NULL
incubation	NULL
medium	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Recent	NULL
advances	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
early	NULL
induction	NULL
of	NULL
junB	NULL
correlates	NULL
with	NULL
phosphorylation	NULL
of	NULL
a	NULL
p160	NULL
protein	NULL
by	NULL
a	NULL
still	NULL
unidentified	NULL
tyrosine	NULL
kinase	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
found	NULL
that	NULL
two	NULL
kinds	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
complex	NULL
control	NULL
of	NULL
junB	NULL
under	NULL
IL-6	NULL
stimulation	NULL
.	NULL

A	NULL
tyrphostin-sensitive	NULL
tyrosine	NULL
kinase	NULL
controlled	NULL
the	NULL
onset	NULL
of	NULL
the	NULL
early	NULL
transient	NULL
expression	NULL
of	NULL
jun	NULL
B	NULL
,	NULL
whereas	NULL
a	NULL
genistein-sensi-tive	NULL
tyrosine	NULL
kinase	NULL
was	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
the	NULL
more	NULL
sustained	NULL
second	NULL
peak	NULL
of	NULL
junB	NULL
mRNA	NULL
.	NULL

Owing	NULL
to	NULL
the	NULL
discriminative	NULL
action	NULL
of	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
,	NULL
we	NULL
may	NULL
postulate	NULL
that	NULL
two	NULL
distinct	NULL
pathways	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
waves	NULL
of	NULL
jun	NULL
B	NULL
,	NULL
that	NULL
are	NULL
each	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
defined	NULL
tyrosine	NULL
kinase	NULL
.	NULL

The	NULL
discriminatory	NULL
effect	NULL
we	NULL
observed	NULL
on	NULL
7TD1	NULL
cells	NULL
between	NULL
these	NULL
two	NULL
compounds	NULL
is	NULL
not	NULL
an	NULL
original	NULL
feature	NULL
.	NULL

For	NULL
example	NULL
,	NULL
on	NULL
NIH3T3	NULL
cells	NULL
,	NULL
tyrphostin	NULL
(	NULL
RG50864	NULL
)	NULL
and	NULL
genistein	NULL
exert	NULL
discriminative	NULL
inhibitory	NULL
effects	NULL
on	NULL
the	NULL
epidermal	NULL
growth	NULL
factor-stimulated	NULL
pathways	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
either	NULL
microtubule	NULL
associated	NULL
protein	NULL
kinase	NULL
(	NULL
49	NULL
)	NULL
or	NULL
p7OS6	NULL
kinase	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
discriminative	NULL
inhibitory	NULL
effects	NULL
among	NULL
tyrphostin	NULL
congeners	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
(	NULL
HER1	NULL
)	NULL
and	NULL
newErB2	NULL
(	NULL
HER2	NULL
)	NULL
which	NULL
share	NULL
80	NULL
%	NULL
sequence	NULL
homology	NULL
in	NULL
the	NULL
kinase	NULL
domain	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Tyrphostins	NULL
can	NULL
also	NULL
discriminate	NULL
between	NULL
p140**	NULL
``	NULL
,	NULL
p185°	NULL
``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
,	NULL
and	NULL
p210®°~	NULL
@	NULL
*	NULL
in	NULL
vitro	NULL
although	NULL
these	NULL
receptor	NULL
species	NULL
only	NULL
differ	NULL
in	NULL
their	NULL
sequence	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Since	NULL
such	NULL
a	NULL
discrepancy	NULL
exists	NULL
among	NULL
tyrphostins	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
to	NULL
expect	NULL
that	NULL
differences	NULL
might	NULL
exist	NULL
between	NULL
the	NULL
action	NULL
of	NULL
genistein	NULL
and	NULL
tyrphostin	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
combination	NULL
of	NULL
different	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
might	NULL
be	NULL
useful	NULL
to	NULL
dissect	NULL
different	NULL
aspects	NULL
of	NULL
the	NULL
IL-6	NULL
response	NULL
.	NULL

Our	NULL
data	NULL
give	NULL
clues	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
repressor	NULL
factor	NULL
that	NULL
negatively	NULL
regulated	NULL
the	NULL
increase	NULL
in	NULL
transcription	NULL
Effect	NULL
of	NULL
IL-6	NULL
on	NULL
junB	NULL
Transcription	NULL
and	NULL
Synthesis	NULL
rate	NULL
of	NULL
the	NULL
second	NULL
peak	NULL
was	NULL
dependent	NULL
of	NULL
the	NULL
occurrence	NULL
of	NULL
the	NULL
first	NULL
peak	NULL
of	NULL
junB	NULL
mRNA	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
second	NULL
wave	NULL
of	NULL
transcripts	NULL
was	NULL
not	NULL
significantly	NULL
modified	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tyrphostin	NULL
that	NULL
abolished	NULL
the	NULL
first	NULL
jun	NULL
B	NULL
mRNA	NULL
peak	NULL
.	NULL

One	NULL
can	NULL
thus	NULL
conclude	NULL
that	NULL
the	NULL
synthesis	NULL
of	NULL
a	NULL
repressor	NULL
factor	NULL
,	NULL
acting	NULL
during	NULL
the	NULL
second	NULL
peak	NULL
,	NULL
was	NULL
not	NULL
dependent	NULL
on	NULL
JunB	NULL
protein	NULL
molecules	NULL
that	NULL
would	NULL
have	NULL
been	NULL
encoded	NULL
by	NULL
early	NULL
junB	NULL
transcripts	NULL
.	NULL

Taken	NULL
collectively	NULL
,	NULL
these	NULL
data	NULL
highly	NULL
suggest	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
two	NULL
waves	NULL
of	NULL
junB	NULL
are	NULL
two	NULL
separate	NULL
events	NULL
controlled	NULL
by	NULL
two	NULL
distinct	NULL
pathways	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
Jak	NULL
congeners	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
mediated	NULL
by	NULL
IL-6	NULL
effects	NULL
has	NULL
been	NULL
clearly	NULL
established	NULL
on	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
16	NULL
,	NULL
17	NULL
,	NULL
53	NULL
)	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
investigating	NULL
a	NULL
possible	NULL
involvement	NULL
of	NULL
this	NULL
family	NULL
of	NULL
tyrosine	NULL
kinases	NULL
in	NULL
our	NULL
model	NULL
,	NULL
especially	NULL
in	NULL
the	NULL
mediation	NULL
of	NULL
junB	NULL
expression	NULL
.	NULL

Owing	NULL
to	NULL
the	NULL
complex	NULL
control	NULL
that	NULL
IL-6	NULL
exerts	NULL
on	NULL
jun	NULL
B	NULL
mRNA	NULL
induction	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
know	NULL
what	NULL
was	NULL
the	NULL
fate	NULL
of	NULL
the	NULL
JunB	NULL
protein	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytokine	NULL
.	NULL

Interestingly	NULL
,	NULL
JunB	NULL
protein	NULL
was	NULL
undetectable	NULL
in	NULL
nucleic	NULL
fractions	NULL
purified	NULL
from	NULL
nonstimulated	NULL
7TD1	NULL
cells	NULL
but	NULL
was	NULL
strongly	NULL
enhanced	NULL
in	NULL
presence	NULL
of	NULL
IL-6	NULL
.	NULL

As	NULL
assessed	NULL
by	NULL
Western	NULL
blotting	NULL
experiments	NULL
,	NULL
the	NULL
protein	NULL
increased	NULL
in	NULL
a	NULL
biphasic	NULL
fashion	NULL
that	NULL
matched	NULL
the	NULL
biphasic	NULL
increase	NULL
of	NULL
mRNA	NULL
and	NULL
the	NULL
transcription	NULL
rate	NULL
.	NULL

The	NULL
JunB	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
two	NULL
waves	NULL
of	NULL
mRNA	NULL
migrated	NULL
as	NULL
a	NULL
monomer	NULL
of	NULL
46	NULL
kDa	NULL
which	NULL
might	NULL
correspond	NULL
to	NULL
the	NULL
molecular	NULL
mass	NULL
of	NULL
a	NULL
phosphorylated	NULL
form	NULL
of	NULL
the	NULL
molecule	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
migration	NULL
pattern	NULL
of	NULL
the	NULL
39-kDa	NULL
unphosphorylated	NULL
recombinant	NULL
protein	NULL
.	NULL

This	NULL
result	NULL
then	NULL
supposes	NULL
that	NULL
IL-6	NULL
not	NULL
only	NULL
increased	NULL
the	NULL
nuclear	NULL
level	NULL
of	NULL
JunB	NULL
but	NULL
could	NULL
also	NULL
stimulate	NULL
the	NULL
phosphorylation	NULL
of	NULL
this	NULL
protein	NULL
.	NULL

On	NULL
a	NULL
mechanistic	NULL
point	NULL
of	NULL
view	NULL
,	NULL
this	NULL
observation	NULL
is	NULL
interesting	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
it	NULL
is	NULL
now	NULL
well	NULL
accepted	NULL
that	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
oncogene-encoded	NULL
proteins	NULL
like	NULL
c-Fos	NULL
,	NULL
c-Jun	NULL
,	NULL
or	NULL
JunB	NULL
might	NULL
control	NULL
their	NULL
binding	NULL
activity	NULL
(	NULL
48	NULL
,	NULL
54-56	NULL
)	NULL
.	NULL

Experiments	NULL
using	NULL
recombinant	NULL
JunB	NULL
protein	NULL
are	NULL
currently	NULL
in	NULL
progress	NULL
,	NULL
aimed	NULL
at	NULL
clarifying	NULL
the	NULL
physiological	NULL
role	NULL
of	NULL
IL-6-dependent	NULL
phosphorylation	NULL
on	NULL
JunB	NULL
binding	NULL
and	NULL
transactivating	NULL
activities	NULL
in	NULL
7TD1	NULL
cells	NULL
.	NULL

To	NULL
date	NULL
,	NULL
the	NULL
main	NULL
interest	NULL
in	NULL
the	NULL
field	NULL
of	NULL
IL-6	NULL
action	NULL
has	NULL
focused	NULL
on	NULL
the	NULL
characterization	NULL
of	NULL
intermediates	NULL
involved	NULL
in	NULL
the	NULL
generation	NULL
and	NULL
the	NULL
propagation	NULL
of	NULL
early	NULL
signals	NULL
triggered	NULL
by	NULL
this	NULL
cytokine	NULL
.	NULL

Using	NULL
jwnB	NULL
oncogene	NULL
as	NULL
a	NULL
molecular	NULL
reporter	NULL
,	NULL
we	NULL
could	NULL
demonstrate	NULL
that	NULL
,	NULL
besides	NULL
its	NULL
early	NULL
action	NULL
,	NULL
IL-6	NULL
also	NULL
stimulates	NULL
mid/long	NULL
term	NULL
events	NULL
.	NULL

By	NULL
the	NULL
use	NULL
of	NULL
cycloheximide	NULL
and	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
we	NULL
were	NULL
able	NULL
to	NULL
reveal	NULL
two	NULL
distinct	NULL
signaling	NULL
routes	NULL
that	NULL
end	NULL
up	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
same	NULL
molecular	NULL
event	NULL
,	NULL
namely	NULL
JunB	NULL
expression	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
control	NULL
of	NULL
the	NULL
two	NULL
peaks	NULL
of	NULL
jun	NULL
B	NULL
mRNA	NULL
differs	NULL
on	NULL
three	NULL
major	NULL
points	NULL
:	NULL
(	NULL
i	NULL
)	NULL
activation	NULL
of	NULL
a	NULL
repressor	NULL
protein	NULL
that	NULL
intervened	NULL
only	NULL
in	NULL
the	NULL
control	NULL
of	NULL
the	NULL
transcription	NULL
rate	NULL
occurring	NULL
during	NULL
the	NULL
second	NULL
peak	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
impeded	NULL
the	NULL
decrease	NULL
in	NULL
the	NULL
second	NULL
burst	NULL
of	NULL
transcription	NULL
rate	NULL
whereas	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytokine	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
onset	NULL
of	NULL
the	NULL
declining	NULL
phase	NULL
of	NULL
the	NULL
first	NULL
peak	NULL
,	NULL
(	NULL
iii	NULL
)	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
allowed	NULL
us	NULL
to	NULL
hypothesize	NULL
that	NULL
two	NULL
distinct	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
control	NULL
each	NULL
of	NULL
the	NULL
two	NULL
peaks	NULL
of	NULL
IL-6-induced	NULL
junB	NULL
transcripts	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
data	NULL
provide	NULL
interesting	NULL
tools	NULL
to	NULL
approach	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
jun	NULL
B	NULL
could	NULL
participate	NULL
in	NULL
the	NULL
mediation	NULL
of	NULL
IL-6	NULL
biological	NULL
effects	NULL
.	NULL

Acknowledgments-We	NULL
want	NULL
to	NULL
express	NULL
our	NULL
sincere	NULL
thanks	NULL
to	NULL
Dr.	NULL
J	NULL
.	NULL

Van	NULL
Snick	NULL
(	NULL
Brussel	NULL
)	NULL
for	NULL
kindly	NULL
providing	NULL
the	NULL
7TD1	NULL
cell	NULL
line	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
M.	NULL
Yaniv	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
)	NULL
for	NULL
generously	NULL
giving	NULL
the	NULL
specific	NULL
antiyunB	NULL
antibody	NULL
(	NULL
JunB	NULL
2.2	NULL
)	NULL
.	NULL

We	NULL
are	NULL
indebted	NULL
to	NULL
R.	NULL
Mescatullo	NULL
for	NULL
illustration	NULL
work	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Andus	NULL
,	NULL
T.	NULL
,	NULL
Geiger	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
Northoff	NULL
,	NULL
H.	NULL
,	NULL
Ganter	NULL
,	NULL
U.	NULL
,	NULL
Bauer	NULL
,	NULL
J.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Heinrich	NULL
,	NULL
P.	NULL
C.	NULL
(	NULL
1987	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

221	NULL
,	NULL
18-22	NULL
2	NULL
.	NULL

3	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

1267	NULL
Gauldie	NULL
,	NULL
J.	NULL
,	NULL
Richards	NULL
,	NULL
C.	NULL
,	NULL
Harnish	NULL
,	NULL
D.	NULL
,	NULL
Landsdorp	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baumann	NULL
,	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
7251-7255	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
Nakano	NULL
,	NULL
N.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Kashiwamura	NULL
,	NULL
S.	NULL
,	NULL
Shimizu	NULL
,	NULL
S.	NULL
,	NULL
Nakajima	NULL
,	NULL
K.	NULL
,	NULL
Pyun	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
5490-5494	NULL
.	NULL

Muragushi	NULL
,	NULL
A.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
Tang	NULL
,	NULL
B.	NULL
,	NULL
Matsuda	NULL
,	NULL
T.	NULL
,	NULL
Horii	NULL
,	NULL
Y.	NULL
,	NULL
Nakajima	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167	NULL
,	NULL
332-344	NULL
.	NULL

Hama	NULL
,	NULL
T.	NULL
,	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Tsukui	NULL
,	NULL
H.	NULL
,	NULL
Nishio	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Hatanaka	NULL
,	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Neurosci	NULL
.	NULL

Lett	NULL
.	NULL

104	NULL
,	NULL
340-344	NULL
.	NULL

Miyaura	NULL
,	NULL
C.	NULL
,	NULL
Onozaki	NULL
,	NULL
K.	NULL
,	NULL
Akiyama	NULL
,	NULL
Y.	NULL
,	NULL
Taniyama	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Suda	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

234	NULL
,	NULL
17-21	NULL
.	NULL

Satoh	NULL
,	NULL
T.	NULL
,	NULL
Nakamura	NULL
,	NULL
S.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
Matsuda	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kaziro	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
3546-3549	NULL
.	NULL

Takai	NULL
,	NULL
Y.	NULL
,	NULL
Wong	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
Clark	NULL
,	NULL
S.	NULL
,	NULL
Burakoff	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Herrmann	NULL
,	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
508-512	NULL
.	NULL

Nordan	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
and	NULL
Potter	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
283	NULL
,	NULL
566-569	NULL
.	NULL

Uyttenhove	NULL
,	NULL
C.	NULL
,	NULL
Coulie	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167	NULL
,	NULL
1417-1427	NULL
Van	NULL
Damme	NULL
,	NULL
J.	NULL
,	NULL
Opdenakker	NULL
,	NULL
G.	NULL
,	NULL
Simpson	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Rubira	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Cayphas	NULL
,	NULL
S.	NULL
,	NULL
Vink	NULL
,	NULL
A.	NULL
,	NULL
Billiau	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165	NULL
,	NULL
914-919	NULL
Kawano	NULL
,	NULL
M.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
Matsuda	NULL
,	NULL
T.	NULL
,	NULL
Horii	NULL
,	NULL
Y.	NULL
,	NULL
Iwato	NULL
,	NULL
H.	NULL
,	NULL
Asaoku	NULL
,	NULL
H.	NULL
,	NULL
Tang	NULL
,	NULL
B.	NULL
,	NULL
Tanaka	NULL
,	NULL
H.	NULL
,	NULL
Kuramoto	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
882	NULL
,	NULL
83-85	NULL
Murakami	NULL
,	NULL
M.	NULL
,	NULL
Narazaki	NULL
,	NULL
M.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Yawata	NULL
,	NULL
H.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Hamaguchi	NULL
,	NULL
M.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
11349-11353	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Hirata	NULL
,	NULL
Y.	NULL
,	NULL
Yamasaki	NULL
,	NULL
K.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Matsuda	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
578-581	NULL
Murakami	NULL
,	NULL
M.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Nakagawa	NULL
,	NULL
N.	NULL
,	NULL
Nakagawa	NULL
,	NULL
T.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Yamanishi	NULL
,	NULL
K.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
260	NULL
,	NULL
1808-1810	NULL
Litticken	NULL
,	NULL
C.	NULL
,	NULL
Wegenka	NULL
,	NULL
U.	NULL
M.	NULL
,	NULL
Yuan	NULL
,	NULL
J.	NULL
,	NULL
Buschmann	NULL
,	NULL
J.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
,	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
Barbieri	NULL
,	NULL
G.	NULL
,	NULL
Pellegrini	NULL
,	NULL
S.	NULL
,	NULL
Sendtner	NULL
,	NULL
M.	NULL
,	NULL
Heinrich	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Horn	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
89-92	NULL
Stahl	NULL
,	NULL
N.	NULL
,	NULL
Boulton	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
Farruggella	NULL
,	NULL
T.	NULL
,	NULL
Ip	NULL
,	NULL
N.	NULL
Y.	NULL
,	NULL
Davis	NULL
,	NULL
S.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Barbieri	NULL
,	NULL
G.	NULL
,	NULL
Pellegrini	NULL
,	NULL
S.	NULL
,	NULL
Thie	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Yancopoulos	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
92-95	NULL
Hattori	NULL
,	NULL
M.	NULL
,	NULL
Abraham	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Northemann	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Fey	NULL
,	NULL
G.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
2364-2368	NULL
Hocke	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Barry	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Fey	NULL
,	NULL
G.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
2282-2294	NULL
Wegenka	NULL
,	NULL
U.	NULL
M.	NULL
,	NULL
Buschmann	NULL
,	NULL
J.	NULL
,	NULL
Liitticken	NULL
,	NULL
C.	NULL
,	NULL
Heinrich	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Horn	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
276-288	NULL
Melamed	NULL
,	NULL
D.	NULL
,	NULL
Resnitzky	NULL
,	NULL
D.	NULL
,	NULL
Haimov	NULL
,	NULL
L.	NULL
,	NULL
Levy	NULL
,	NULL
N.	NULL
,	NULL
Pfarr	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Yaniv	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kimchi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

4	NULL
,	NULL
689-698	NULL
Melamed	NULL
,	NULL
D.	NULL
,	NULL
Tiefenbrun	NULL
,	NULL
N.	NULL
,	NULL
Yarden	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kimchi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
5255-5265	NULL
Poli	NULL
,	NULL
V.	NULL
,	NULL
Mancini	NULL
,	NULL
F.	NULL
P.	NULL
,	NULL
and	NULL
Cortese	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
643-653	NULL
Harroch	NULL
,	NULL
S.	NULL
,	NULL
Revel	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Chebath	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
1942-1949	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
95-98	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Isshiki	NULL
,	NULL
H.	NULL
,	NULL
Sugita	NULL
,	NULL
T.	NULL
,	NULL
Tanabe	NULL
,	NULL
O.	NULL
,	NULL
Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
Nishio	NULL
,	NULL
Y.	NULL
,	NULL
Nakajima	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
.J	NULL
.	NULL

9	NULL
,	NULL
1897-1906	NULL
Nakajima	NULL
,	NULL
T.	NULL
,	NULL
Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
Sasagawa	NULL
,	NULL
T.	NULL
,	NULL
Sasaki	NULL
,	NULL
K.	NULL
,	NULL
Naruto	NULL
,	NULL
M.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Akira	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
2207-2211	NULL
Wegenka	NULL
,	NULL
U.	NULL
M.	NULL
,	NULL
Liitticken	NULL
,	NULL
C.	NULL
,	NULL
Buschmann	NULL
,	NULL
J.	NULL
,	NULL
Yuan	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Miiller-Esterl	NULL
,	NULL
W.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Roeb	NULL
,	NULL
E.	NULL
,	NULL
Heinrich	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Horn	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
3186-3196	NULL
Lord	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Abdollahi	NULL
,	NULL
A.	NULL
,	NULL
Thomas	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
De	NULL
Marco	NULL
,	NULL
M.	NULL
,	NULL
Brugge	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Hoffman-Liebermann	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Liebermann	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4371-4379	NULL
Nakajima	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Wall	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1409-1418	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
and	NULL
Bos	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Adv	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

55	NULL
,	NULL
1-35	NULL
Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Petryniak	NULL
,	NULL
B.	NULL
,	NULL
Mao	NULL
,	NULL
X.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
Lindsten	NULL
,	NULL
T.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
Kovary	NULL
,	NULL
K.	NULL
,	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
1911-1919	NULL
Nakajima	NULL
,	NULL
K.	NULL
,	NULL
Kusafuka	NULL
,	NULL
T.	NULL
,	NULL
Takeda	NULL
,	NULL
T.	NULL
,	NULL
Fujitani	NULL
,	NULL
Y.	NULL
,	NULL
Nakae	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hirano	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3027-3041	NULL
Proudfoot	NULL
,	NULL
A.	NULL
E.	NULL
I.	NULL
,	NULL
Brown	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Bernard	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Bonnefoy	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
and	NULL
Kawashima	NULL
,	NULL
E.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
J	NULL
.	NULL

Protein	NULL
Chem	NULL
.	NULL

12	NULL
,	NULL
489-497	NULL
Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
Ryder	NULL
,	NULL
K.	NULL
,	NULL
Lau	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Nathan	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
1487-1491	NULL
Doglio	NULL
,	NULL
A.	NULL
,	NULL
Dani	NULL
,	NULL
C.	NULL
,	NULL
Grimaldi	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Ailhaud	NULL
,	NULL
G.	NULL
(	NULL
1986	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

238	NULL
,	NULL
123-129	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovits	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1479	NULL
Ryder	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
8464-8467	NULL
Trejo	NULL
,	NULL
J.	NULL
,	NULL
Chambard	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Brown	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4742-4750	NULL
Carter	NULL
,	NULL
R.	NULL
,	NULL
Cosenza	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Pena	NULL
,	NULL
A.	NULL
,	NULL
Lipson	NULL
,	NULL
K.	NULL
,	NULL
Soprano	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Soprano	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
229-235	NULL
Pulverer	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Hugues	NULL
,	NULL
K.	NULL
,	NULL
Franklin	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Leevers	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
407-415	NULL
Kovary	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4466-4472	NULL
Schiitte	NULL
,	NULL
J.	NULL
,	NULL
Viallet	NULL
,	NULL
J.	NULL
,	NULL
Nau	NULL
,	NULL
M.	NULL
,	NULL
Segal	NULL
,	NULL
S.	NULL
,	NULL
Fedorko	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Minna	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
987-997	NULL
Castellazzi	NULL
,	NULL
M.	NULL
,	NULL
Spyrou	NULL
,	NULL
G.	NULL
,	NULL
La	NULL
Vista	NULL
,	NULL
N.	NULL
,	NULL
Dangy	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Piu	NULL
,	NULL
F.	NULL
,	NULL
Yaniv	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Brun	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
8890-8894	NULL
De	NULL
Groot	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Auwerx	NULL
,	NULL
J.	NULL
,	NULL
Karperien	NULL
,	NULL
M.	NULL
,	NULL
Staels	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Kruijer	NULL
,	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
775-780	NULL
Kitabayashi	NULL
,	NULL
L	NULL
,	NULL
Kawakami	NULL
,	NULL
Z.	NULL
,	NULL
Matsuoka	NULL
,	NULL
T.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Gachelin	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Yokoyama	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
14482-14489	NULL
Kovary	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2451-2459	NULL
1268	NULL
Effect	NULL
of	NULL
IL-6	NULL
on	NULL
junB	NULL
Transcription	NULL
and	NULL
Synthesis	NULL
49	NULL
.	NULL

Agbotounou	NULL
,	NULL
W.	NULL
K.	NULL
,	NULL
Mousset	NULL
,	NULL
S.	NULL
,	NULL
Piperno	NULL
,	NULL
S.	NULL
,	NULL
Pierre	NULL
,	NULL
M.	NULL
,	NULL
Jacquemin-Sablon	NULL
,	NULL
A.	NULL
,	NULL
53	NULL
.	NULL

Narazaki	NULL
,	NULL
M.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Yoshida	NULL
,	NULL
K.	NULL
,	NULL
Siivennoinen	NULL
,	NULL
O.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Pierre	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

Pharmacol	NULL
.	NULL

48	NULL
,	NULL
505-515	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taga	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Nati	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

50	NULL
,	NULL
Linassier	NULL
,	NULL
C.	NULL
,	NULL
Pierre	NULL
,	NULL
M.	NULL
,	NULL
Le	NULL
Pecq	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Pierre	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Biochem	NULL
.	NULL

91	NULL
,	NULL
2285-2289	NULL
Pharmacol	NULL
.	NULL

89	NULL
,	NULL
187-193	NULL
54	NULL
.	NULL

Binetruy	NULL
,	NULL
B.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
351	NULL
,	NULL
122-127	NULL
51	NULL
.	NULL

Levitzky	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

6	NULL
,	NULL
3275-3282	NULL
55	NULL
.	NULL

Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Defize	NULL
,	NULL
L.	NULL
H.	NULL
K.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Woodgett	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
52	NULL
.	NULL

Anafi	NULL
,	NULL
M.	NULL
,	NULL
Gazit	NULL
,	NULL
A.	NULL
,	NULL
Gilon	NULL
,	NULL
C.	NULL
,	NULL
Ben-Neriah	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Levitzki	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

and	NULL
Hunter	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
573-584	NULL
Chem	NULL
.	NULL

267	NULL
,	NULL
4518-4523	NULL
56	NULL
.	NULL

Offir	NULL
,	NULL
R.	NULL
,	NULL
Dwarki	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
Rashid	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
848	NULL
,	NULL
78-80	NULL

